Any feedback?
Information on EC 3.1.3.3 - phosphoserine phosphatase and Organism(s) Homo sapiens
for references in articles please use BRENDA:EC3.1.3.3Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
3.1.3.3 phosphoserine phosphataseSpecify your search results
Word Map
- 3.1.3.3
-
supranuclear
- palsy
- atrophy
- degeneration
- neurodegenerative
- tau
-
corticobasal
- dementia
- alzheimer
-
parkinsonian
-
frontal
-
shellfish
- pneumothorax
-
paralytic
-
neurofibrillary
-
neuropathological
- tauopathies
- tangle
-
poison
-
frontotemporal
- midbrain
-
postsynaptic
- chest
-
gaze
-
subcortical
-
dinoflagellate
-
video-assisted
-
thoracoscopic
-
saxitoxin
-
postural
-
pseudopregnancy
- levodopa
-
richardson
-
voxel-based
-
monosynaptic
-
subthalamic
- bradykinesia
-
oculomotor
-
apathy
-
argyrophilic
-
precentral
-
pedunculopontine
- analysis
-
akinesia
-
saccade
- medicine
- apraxia
-
updrs
- bulla
-
tegmentum
-
peduncle
-
pleurodesis
The taxonomic range for the selected organisms is: Homo sapiens
The expected taxonomic range for this enzyme is: Bacteria, Eukaryota, Archaea
The expected taxonomic range for this enzyme is: Bacteria, Eukaryota, Archaea
Synonyms
psp, serine/threonine protein phosphatase, phosphoserine phosphatase, pspase, ctd phosphatase fcp1, serb653, serb2, l-phosphoserine phosphatase, 3-phosphoserine phosphatase, ipsp1, 
more
topPlease wait a moment until the data is sorted. This message will disappear when the data is sorted.
SYNONYM 
ORGANISM
UNIPROT
COMMENTARY 
LITERATURE
3-phosphoserine phosphatase
-
-
-
-
CTD phosphatase fcp1
-
-
-
-
O-phosphoserine phosphohydrolase
-
-
-
-
phosphatase, phosphoserine
-
-
-
-
PSP
PSPase
-
-
-
-
PSPH
PSP
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
hydrolysis of phosphoric ester
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PATHWAY SOURCE
PATHWAYS
BRENDA
KEGG
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SYSTEMATIC NAME
IUBMB Comments
O-phosphoserine phosphohydrolase
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CAS REGISTRY NUMBER
COMMENTARY
9025-73-4
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SUBSTRATE
PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate)
(Substrate)
LITERATURE
(Substrate)
(Substrate)
COMMENTARY
(Product)
(Product)
LITERATURE
(Product)
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
L-O-phosphoserine + H2O
L-serine + phosphate
-
enzyme is responsible for the third and final step of the L-serine biosynthetic pathway
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate)
(Substrate)
LITERATURE
(Substrate)
(Substrate)
COMMENTARY
(Product)
(Product)
LITERATURE
(Product)
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
L-O-phosphoserine + H2O
L-serine + phosphate
-
enzyme is responsible for the third and final step of the L-serine biosynthetic pathway
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Mg2+
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
Ca2+
-
inhibition even in presence of Mg2+, replacement of sixfold coordinated Mg2+ in active site by Ca2+ results in sevenfold coordinated metal ion, explaining the inhibitory effect of Ca2+
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Acidosis
Cytochalasin D reduces Ca2+ currents via cofilin-activated depolymerization of F-actin in guinea-pig cardiomyocytes.
Acne Vulgaris
Evaluation of PSP technique including dot peeling, subcision and intradermal injection of PRP in the treatment of atrophic post-acne scars.
aconitate hydratase deficiency
Brain aconitase activity is not decreased in progressive supranuclear palsy.
Acquired Immunodeficiency Syndrome
Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy.
Acquired Immunodeficiency Syndrome
Long-term perspective on the prevalent-cohort biases in studies of human immunodeficiency virus progression.
Acute Kidney Injury
A validation of presepsin levels in kidney dysfunction patients: four case reports.
Adenocarcinoma
A case of pulmonary sclerosing pneumocytoma diagnosed preoperatively using transbronchial cryobiopsy.
Adenocarcinoma
Positive Resection Margins Detected by Standardized Study of a Pancreaticoduodenectomy Sample: Is There Any Real Impact on Long-term Survival?
Adenocarcinoma
Pulmonary sclerosing pneumocytoma with mediastinal lymph node metastasis: a case report.
Adenoma
Interendoscopist variability in proximal colon polyp detection is twice higher for serrated polyps than adenomas.
Adenoma
Pituitary tumors contain a side population with tumor stem cell-associated characteristics.
Adenoma
Relationships of parathyroid hormone, parathyroid secretory protein, parathyroid hormone messenger RNA, parathyroid secretory protein mRNA, and replication in human parathyroid adenoma and secondary hyperplasia tissues and cultures.
Adenoma, Pleomorphic
Pleomorphic adenoma: extracapsular dissection versus partial superficial parotidectomy with facial nerve dissection.
Alzheimer Disease
Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.
Alzheimer Disease
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.
Alzheimer Disease
An association study of common variation at the MAPT locus with late-onset Alzheimer's disease.
Alzheimer Disease
An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
Alzheimer Disease
Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
Alzheimer Disease
Antigenic characteristics of neurofibrillary tangles in progressive supranuclear palsy.
Alzheimer Disease
Applause sign: is it really specific for Parkinsonian disorders? Evidence from cortical dementias.
Alzheimer Disease
Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies.
Alzheimer Disease
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.
Alzheimer Disease
Brain somatostatin concentrations do not decrease in progressive supranuclear palsy.
Alzheimer Disease
Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles.
Alzheimer Disease
Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging.
Alzheimer Disease
CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP.
Alzheimer Disease
Cytokine expression and microglial activation in progressive supranuclear palsy.
Alzheimer Disease
Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats.
Alzheimer Disease
Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases.
Alzheimer Disease
Essential tremor followed by progressive supranuclear palsy: postmortem reports of 11 patients.
Alzheimer Disease
Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases.
Alzheimer Disease
Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans.
Alzheimer Disease
Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Alzheimer Disease
Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice.
Alzheimer Disease
Lewy bodies in progressive supranuclear palsy represent an independent disease process.
Alzheimer Disease
Lipoperoxidation is selectively involved in progressive supranuclear palsy.
Alzheimer Disease
Muscarinic receptors in the thalamus in progressive supranuclear palsy and other neurodegenerative disorders.
Alzheimer Disease
Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome.
Alzheimer Disease
Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau.
Alzheimer Disease
Neuronal loss in the basal nucleus of Meynert in progressive supranuclear palsy.
Alzheimer Disease
Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.
Alzheimer Disease
Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease.
Alzheimer Disease
Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease.
Alzheimer Disease
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
Alzheimer Disease
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy.
Alzheimer Disease
PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.
Alzheimer Disease
Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
Alzheimer Disease
Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders.
Alzheimer Disease
Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other Tauopathies.
Alzheimer Disease
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).
Alzheimer Disease
Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options.
Alzheimer Disease
Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like magnetic resonance imaging features.
Alzheimer Disease
Progressive supranuclear palsy with fronto-temporal atrophy and various tau-positive abnormal structures.
Alzheimer Disease
Progressive supranuclear palsy: neuropathologic and clinical heterogeneity.
Alzheimer Disease
Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease.
Alzheimer Disease
Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy.
Alzheimer Disease
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy.
Alzheimer Disease
Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
Alzheimer Disease
Tau and saitohin gene expression pattern in progressive supranuclear palsy.
Alzheimer Disease
Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
Alzheimer Disease
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
Alzheimer Disease
Tau Imaging in the 4-Repeat-Tauopathies Progressive Supranuclear Palsy and Corticobasal Syndrome: A 11C-Pyridinyl-Butadienyl-Benzothiazole 3 PET Pilot Study.
Alzheimer Disease
The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases.
Alzheimer Disease
The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.
Alzheimer Disease
The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease.
Alzheimer Disease
The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases.
Alzheimer Disease
The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease.
Alzheimer Disease
Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans.
Alzheimer Disease
[An autopsy case of postencephalitic parkinsonism: investigation on neurofibrillary tangles in comparison with those in progressive supranuclear palsy]
Alzheimer Disease
[Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report].
Amyotrophic Lateral Sclerosis
Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Amyotrophic Lateral Sclerosis
Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels.
Amyotrophic Lateral Sclerosis
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.
Amyotrophic Lateral Sclerosis
Progress in clinical neurosciences: Frontotemporal dementia-pick's disease.
Amyotrophic Lateral Sclerosis
The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease.
Amyotrophic Lateral Sclerosis
Under-recognized primary spontaneous pneumothorax in ALS: a multicenter retrospective study.
Aneurysm
Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm.
Aneurysm
[A case of a syndrome resembling PSP after aortic arch replacement under deep hypothermic circulatory arrest].
Angina, Stable
The role of polysaccharide peptide of Ganoderma lucidum as a potent antioxidant against atherosclerosis in high risk and stable angina patients.
Anhedonia
Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
Anhedonia
Negative symptoms and everyday functioning in schizophrenia: a cross-sectional study in a real world-setting.
Anosmia
Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients.
Anthracosis
Fluorescein-enhanced Autofluorescence Thoracoscopy in Patients with Primary Spontaneous Pneumothorax and Normal Subjects.
Aphasia
Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia.
Aphasia
Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.
Aphasia
Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration.
Aphasia
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy.
Aphasia
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
Aphasia
Family history of frontotemporal lobar degeneration in Asia - an international multi-center research.
Aphasia
First symptom guides diagnosis and prognosis in neurodegenerative diseases-a retrospective study of autopsy proven cases.
Aphasia
Frontal dynamic aphasia in progressive supranuclear palsy: Distinguishing between generation and fluent sequencing of novel thoughts.
Aphasia
Negative symptoms and everyday functioning in schizophrenia: a cross-sectional study in a real world-setting.
Aphasia
Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease.
Aphasia
Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy.
Aphasia
The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.
Aphasia, Broca
Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy.
Aphasia, Primary Progressive
Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.
Aphasia, Primary Progressive
Language impairment in progressive supranuclear palsy and corticobasal syndrome.
Aphasia, Primary Progressive
Progressive supranuclear palsy presenting with primary progressive aphasia--clinicopathological report of an autopsy case.
Aphasia, Primary Progressive
Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
Aphasia, Primary Progressive
[A 62-year-old Woman Presenting with Progressive Nonfluent Aphasia, Apraxia of Eyelid Opening, Supranuclear Gaze Palsy, and Asymmetric Rigidity].
Aphasia, Primary Progressive
[Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis]
Apraxia, Ideomotor
Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
Apraxia, Ideomotor
Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration.
Apraxia, Ideomotor
Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy.
Apraxia, Ideomotor
Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes.
Apraxia, Ideomotor
Cognitive dysfunction associated with falls in progressive supranuclear palsy.
Apraxia, Ideomotor
Distal-proximal differences in limb apraxia in corticobasal degeneration but not progressive supranuclear palsy.
Apraxia, Ideomotor
Limb apraxia and cognitive impairment in progressive supranuclear palsy.
Apraxia, Ideomotor
Limb apraxia in corticobasal degeneration and progressive supranuclear palsy.
Apraxias
Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
Apraxias
Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy.
Apraxias
Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia.
Apraxias
Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center.
Apraxias
How to spot ocular abnormalities in progressive supranuclear palsy? A practical review.
Apraxias
Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Apraxias
Long-term locomotor training for gait and balance in a patient with mixed progressive supranuclear palsy and corticobasal degeneration.
Apraxias
Motor Speech Disorders and Communication Limitations in Progressive Supranuclear Palsy.
Apraxias
Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Apraxias
Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
Apraxias
The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.
Apraxias
[A 68-year-old man with speech disturbance as the initial symptom followed by bradykinesia and dementia. Clinical conference]
Apraxias
[A case of progressive supranuclear palsy presenting mouth opening difficulty with tonic contraction of the orbicularis oris muscle]
Arthritis
Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.
Arthritis, Psoriatic
Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.
Astrocytoma
Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma.
Ataxia
Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center.
Ataxia
Effects of organophosphate phenyl saligenin phosphate and polyether carboxylic ionophore lasalocid on motor nerve conduction velocity, neuropathy target esterase enzyme activity, and clinical ataxia in chickens.
Ataxia
Modification of phenyl saligenin phosphate-induced delayed effects by calcium channel blockers: in vivo and in vitro electrophysiological assessment.
Ataxia
Types of adrenocorticoids and their effect on organophosphorus-induced delayed neuropathy in chickens.
Atherosclerosis
Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2.
Atherosclerosis
The reduction of aorta histopathological images through inhibition of reactive oxygen species formation in hypercholesterolemia rattus norvegicus treated with polysaccharide peptide of Ganoderma lucidum.
Atherosclerosis
The role of polysaccharide peptide of Ganoderma lucidum as a potent antioxidant against atherosclerosis in high risk and stable angina patients.
Atrial Fibrillation
Alterations in the interactome of serine/threonine protein phosphatase type-1 in atrial fibrillation patients.
Atrial Fibrillation
Post-stroke pneumonia at the stroke unit - a registry based analysis of contributing and protective factors.
Atrial Fibrillation
Prolonged Sinus Pauses upon Termination of Paroxysmal Atrial Fibrillation: Abnormal Right Atrial Electrophysiologic and Electroanatomic Findings.
Atrial Fibrillation
Risk factors for and impact of poststroke pneumonia in patients with acute ischemic stroke.
Atrial Fibrillation
Risk stratification model for post-stroke pneumonia in patients with acute ischemic stroke.
Autoimmune Diseases
Autoantibodies, detection methods and panels for diagnosis of Sjögren's syndrome.
Autoimmune Diseases
Polysaccharopeptide mimics ciclosporin-mediated Th1/Th2 cytokine balance for suppression of activated human T cell proliferation by MAPKp38 and STAT5 pathways.
Autoimmune Diseases
Regulatory properties of polysaccharopeptide derived from Coriolus versicolor and its combined effect with ciclosporin on the homeostasis of human lymphocytes.
Azotemia
Relationship of selected clinical renal function tests to glomerular filtration rate and renal blood flow in cats.
Bacterial Infections
Clinical application of presepsin as diagnostic biomarker of infection: overview and updates.
Bacterial Infections
Plasmatocyte-spreading peptide (PSP) plays a central role in insect cellular immune defenses against bacterial infection.
Basal Ganglia Diseases
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy.
Basal Ganglia Diseases
Progressive supranuclear palsy: clinico-pathological and biochemical studies.
Biliary Fistula
[Benign obstruction of the common bile duct: what is the current role of transduodenal sphincteroplasty?]
Birt-Hogg-Dube Syndrome
Mutation analysis of the FLCN gene in Chinese patients with sporadic and familial isolated primary spontaneous pneumothorax.
Blepharospasm
Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Blepharospasm
How to spot ocular abnormalities in progressive supranuclear palsy? A practical review.
Blister
A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax.
Blister
A deep azygoesophageal recess may increase the risk of secondary spontaneous pneumothorax.
Blister
Alveolar epithelial permeability in patients with primary spontaneous pneumothorax as determined by Tc-99m DTPA aerosol scintigraphy.
Blister
Association between postoperative bulla neogenesis at the staple line and resected lung weight for primary spontaneous pneumothorax: a retrospective study using the inverse-probability of treatment weighted method in patients grouped according to age.
Blister
Association of MMP-2 and MMP-9 expression with recurrences in primary spontaneous pneumothorax.
Blister
Bilateral primary spontaneous pneumothorax with multiple bleb performed by VATS and wedge resection: A rare case in Indonesian adult and review article.
Blister
Can CT scanning be used to select patients with unilateral primary spontaneous pneumothorax for bilateral surgery?
Blister
Comparison of additional minocycline versus iodopovidone pleurodesis during video-assisted thoracoscopic bleb resection for primary spontaneous pneumothorax: a propensity score-matched analysis.
Blister
Contralateral bulla neogenesis associated with postoperative recurrences of primary spontaneous pneumothorax in young patients.
Blister
Correlation of matrix metalloproteinase-2 and -9 expression with recurrences in primary spontaneous pneumothorax patients.
Blister
Do Blebs or Bullae on High-Resolution Computed Tomography Predict Ipsilateral Recurrence in Young Patients at the First Episode of Primary Spontaneous Pneumothorax?
Blister
Efficacy of blebs detection for preventive surgery in children's idiopathic spontaneous pneumothorax.
Blister
ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax.
Blister
Expression of TGF-beta receptor 1 and Smads in the tissues of primary spontaneous pneumothorax.
Blister
First Episode of Spontaneous Pneumothorax: CT-based Scoring to Select Patients for Early Surgery.
Blister
High-Resolution CT Following Primary Spontaneous Pneumothorax in Adolescents: Useful Tool or Wasted Radiation?
Blister
Influence of lung resection volume on risk of primary spontaneous pneumothorax recurrence.
Blister
Is it a myth to perform blind apical wedge resection in primary spontaneous pneumothorax surgery to improve recurrence rates?
Blister
Male adolescents with contralateral blebs undergoing surgery for primary spontaneous pneumothorax may benefit from simultaneous contralateral blebectomies.
Blister
Metachronous recurrent pediatric primary spontaneous pneumothorax: A case presentation and literature review.
Blister
Natural Course of Spontaneous Pneumothorax without Bullae or Blebs under High-Resolution Computed Tomography.
Blister
Neo-generation of neogenetic bullae after surgery for spontaneous pneumothorax in young adults: a prospective study.
Blister
New insights and improved strategies for the management of primary spontaneous pneumothorax.
Blister
One hundred consecutive cases of video-assisted thoracoscopic surgery for primary spontaneous pneumothorax.
Blister
Physical fitness after apical resection for the treatment of primary spontaneous pneumothorax.
Blister
Primary spontaneous pneumothorax in children: factors predicting recurrence and contralateral occurrence.
Blister
Primary spontaneous pneumothorax in children: the role of CT in guiding management.
Blister
Relationship between postoperative bulla neogenesis at the staple line and the resected lung volume in primary spontaneous pneumothorax.
Blister
Role of Blebs and Bullae Detected by High-Resolution Computed Tomography and Recurrent Spontaneous Pneumothorax.
Blister
Severity of Pectus Excavatum is a Risk Factor for Primary Spontaneous Pneumothorax.
Blister
Simultaneous Bilateral Video-Assisted Thoracoscopic Surgery for the Treatment of Primary Spontaneous Pneumothorax.
Blister
Surgical Intervention for Primary Spontaneous Pneumothorax in Pediatric Population: When and Why?
Blister
The Presence of a Reticulated Trabecula-Like Structure Increases the Risk for the Recurrence of Primary Spontaneous Pneumothorax after Thoracoscopic Bullectomy.
Blister
Unilateral single-port thoracoscopic surgery for bilateral pneumothorax or pulmonary bullae.
Blister
Uniportal approach as an alternative to the three-portal approach to video-assisted thoracic surgery for primary spontaneous pneumothorax.
Blister
Value of computer tomography in the detection of bullae and blebs in patients with primary spontaneous pneumothorax.
Blister
Vascular-penetration defect detected in parietal pleura of primary spontaneous pneumothorax.
Blister
Video-assisted extrathoracic bleb excision: An ultra-minithoracotomy for primary spontaneous pneumothorax.
Blister
Video-assisted thoracoscopic surgery (VATS) for bilateral primary spontaneous pneumothorax.
Blister
Video-assisted thoracoscopic surgery for primary spontaneous pneumothorax: clinicopathological correlation.
Blister
Video-assisted thoracoscopic suture closure of blebs to treat primary spontaneous pneumothorax.
Blister
Videothoracoscopic treatment of primary spontaneous pneumothorax: a 6-year experience.
Blister
What Factors Predict Recurrence after an Initial Episode of Primary Spontaneous Pneumothorax in Children?
Bone Diseases, Metabolic
Abnormal bone mineral density and bone turnover marker expression profiles in patients with primary spontaneous pneumothorax.
Bone Resorption
Abnormal bone mineral density and bone turnover marker expression profiles in patients with primary spontaneous pneumothorax.
Bone Resorption
Role of Porphyromonas gingivalis phosphoserine phosphatase enzyme SerB in inflammation, immune response, and induction of alveolar bone resorption in rats.
Botulism
[Clinical analysis of paralytic shellfish poisoning following ingestion of oysters]
Bradycardia
Perinatal and infant outcomes of prenatal diagnosis of heterotaxy syndrome (asplenia and polysplenia).
Brain Diseases
Parkinsonian Syndrome with Frontal Lobe Involvement and Anti-Glycine Receptor Antibodies.
Brain Diseases
Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations.
Brain Injuries
Cerebrospinal Fluid Presepsin As a Marker of Nosocomial Infections of the Central Nervous System: A Prospective Observational Study.
Brain Injuries, Traumatic
Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans.
Brain Ischemia
Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses.
Brain Neoplasms
Diagnostic value of radiolabeled amino acid PET for detection of pseudoprogression of brain tumor after treatment: a meta-analysis.
Breast Neoplasms
A murine preclinical syngeneic transplantation model for breast cancer precision medicine.
Breast Neoplasms
Anti- RI antibody associated progressive supranuclear palsy like presentation in a patient with breast carcinoma.
Breast Neoplasms
Cell cycle-independent regulation of p21Waf1/Cip1 and retinoblastoma protein during okadaic acid-induced apoptosis is coupled with induction of Bax protein in human breast carcinoma cells.
Breast Neoplasms
Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.
Breast Neoplasms
Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells.
Breast Neoplasms
Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening.
Breast Neoplasms
Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23.
Breast Neoplasms
Polysaccharide peptide mediates apoptosis by up-regulating p21 gene and down-regulating cyclin D1 gene.
Breast Neoplasms
Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30.
Breast Neoplasms
PPM1B depletion in U2OS cells supresses cell growth through RB1-E2F1 pathway and stimulates bleomycin-induced cell death.
Breast Neoplasms
The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease.
Breast Neoplasms
The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation.
Bronchiectasis
Multifocal neuroendocrine cell hyperplasia accompanied by tumorlet formation and pulmonary sclerosing pneumocytoma: A case report.
Bronchiolitis
New insights and improved strategies for the management of primary spontaneous pneumothorax.
Bronchitis, Chronic
Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China.
Bulbar Palsy, Progressive
[Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of a case and review of the literature]
Carcinogenesis
Phosphatase Wip1 as a new therapeutic target for intestinal ischemia-reperfusion injury.
Carcinoid Tumor
68Ga-DOTATATE-avid pulmonary sclerosing pneumocytoma in a man of North African descent: Case report, imaging findings and pathology.
Carcinoid Tumor
A case of pulmonary sclerosing pneumocytoma diagnosed preoperatively using transbronchial cryobiopsy.
Carcinoma
Differences in association of the serine/threonine protein phosphatase PP-2A with microtubules of metastatic and nonmetastatic tumor cells.
Carcinoma
Dihydroxyphenylethanol induces apoptosis by activating serine/threonine protein phosphatase PP2A and promotes the endoplasmic reticulum stress response in human colon carcinoma cells.
Carcinoma
Enhancing the utility of Proteomics Signature Profiling (PSP) with Pathway Derived Subnets (PDSs), performance analysis and specialised ontologies.
Carcinoma
FLCN-regulated miRNAs suppressed reparative response in cells and pulmonary lesions of Birt-Hogg-Dubé syndrome.
Carcinoma
Inducible expression of catalytically active type 1 serine/threonine protein phosphatase in a human carcinoma cell line.
Carcinoma
Radical resection of gastric carcinoma with pancreas and spleen preservation and functional cleaning of lymph nodes.
Carcinoma
Serine/threonine protein phosphatase type 1gamma1 is required for the completion of cytokinesis in human A549 lung carcinoma cells.
Carcinoma
[A fluorescent dye method based on changes in membrane potential for detecting PSP toxins in shellfish]
Carcinoma
[Analysis of Clinical Characteristics of 35 Cases ?of Pulmonary Sclerosing Pneumocytoma].
Carcinoma
[Resection of gastric carcinoma with preserving of the spleen and pancreas and functional clearance lymph nodes of the spleen hillus and splenic artery]
Carcinoma, Hepatocellular
cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions.
Carcinoma, Hepatocellular
Down regulation of a novel protein, PSP, in rat hepatoma cdRLh 84-beared tumor.
Carcinoma, Hepatocellular
Recombinant expression of perchloric acid-soluble protein reduces cell proliferation.
Carcinoma, Lewis Lung
Differences in association of the serine/threonine protein phosphatase PP-2A with microtubules of metastatic and nonmetastatic tumor cells.
Carcinoma, Non-Small-Cell Lung
Enhancing the utility of Proteomics Signature Profiling (PSP) with Pathway Derived Subnets (PDSs), performance analysis and specialised ontologies.
Carcinoma, Non-Small-Cell Lung
Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients.
Carcinoma, Renal Cell
FLCN-regulated miRNAs suppressed reparative response in cells and pulmonary lesions of Birt-Hogg-Dubé syndrome.
Carcinoma, Squamous Cell
[Analysis of Clinical Characteristics of 35 Cases ?of Pulmonary Sclerosing Pneumocytoma].
Carcinoma, Transitional Cell
[A fluorescent dye method based on changes in membrane potential for detecting PSP toxins in shellfish]
Cardiomegaly
Functional and phenotypic relevance of differentially expressed proteins in calcineurin mutants of Caenorhabditis elegans.
Cardiomegaly
Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin-interacting protein 1.
Cardiomegaly
Structures of calcineurin and its complexes with immunophilins-immunosuppressants.
Cardiomegaly
The essential role of MEKK3 signaling in angiotensin II-induced calcineurin/nuclear factor of activated T-cells activation.
Cardiomegaly
The role of modulatory calcineurin-interacting proteins in calcineurin signaling.
Cardiovascular Diseases
A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study.
Cardiovascular Diseases
ECHOCARDIOGRAPHIC CHARACTERISTICS OF DIFFERENT WHO/ISH CARDIOVASCULAR DISEASE RISK GROUPS.
Cardiovascular Infections
Clinical application of presepsin as diagnostic biomarker of infection: overview and updates.
Cataract
[Experimental study of changes in the pressure of the posterior segment of the eye under general anesthesia. Consequences for surgery of the anterior segment]
Cellulitis
Which outcomes are reported in cellulitis trials? Results of a review of outcomes included in cellulitis trials and a patient priority setting survey.
Cerebellar Ataxia
Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.
Cerebellar Ataxia
Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study.
Cerebellar Ataxia
Differences in cerebellar perfusion between Parkinson's disease and multiple system atrophy.
Cerebellar Ataxia
Effects of cerebellar neuromodulation in movement disorders: A systematic review.
Cerebellar Ataxia
FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations.
Cerebellar Ataxia
Progressive Supranuclear Gaze Palsy with Predominant Cerebellar Ataxia: A Case Series with Videos.
Cerebellar Ataxia
The linear vestibulo-ocular reflex, locomotion and falls in neurological disorders.
Cerebellar Ataxia
Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia: Case report.
Cerebellar Ataxia
When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients.
Cerebellar Diseases
Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes.
Cerebellar Diseases
Deciphering the saccade velocity profile of progressive supranuclear palsy: A sign of latent cerebellar/brainstem dysfunction?
Cerebral Cortical Thinning
18F-AV1451 PET imaging and multimodal MRI changes in progressive supranuclear palsy.
Cerebral Cortical Thinning
Integrated 18F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders.
Cerebral Infarction
Protective effect of polysaccharide peptide on cerebral ischemia?reperfusion injury in rats.
Cerebral Infarction
Risk factors for and impact of poststroke pneumonia in patients with acute ischemic stroke.
Cerebrovascular Disorders
Clinical Features Observed in General Practice Associated With the Subsequent Diagnosis of Progressive Supranuclear Palsy.
Cerebrovascular Disorders
Lack of association between progressive supranuclear palsy and arterial hypertension: a clinicopathological study.
Cerebrovascular Disorders
No evidence of CRHR1 gene involvement in progressive supranuclear palsy.
Cholangiocarcinoma
Comparison of intraluminal radiofrequency ablation and stents vs. stents alone in the management of malignant biliary obstruction.
Cholera
Regulation of the transmodulated epidermal growth factor receptor by cholera toxin and the protein phosphatase inhibitor okadaic acid.
Chronic Traumatic Encephalopathy
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.
Chronic Traumatic Encephalopathy
Frontrunner in Translation: Progressive Supranuclear Palsy.
Colitis, Ulcerative
Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.
Colonic Neoplasms
Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers.
Colorectal Neoplasms
A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax.
Colorectal Neoplasms
Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.
Colorectal Neoplasms
Inhibition of phosphoserine phosphatase enhances the anticancer efficacy of 5-fluorouracil in colorectal cancer.
Colorectal Neoplasms
Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer.
Confusion
Limited usefulness of electroconvulsive therapy in progressive supranuclear palsy.
Confusion
qPCR assays for Alexandrium fundyense and A. ostenfeldii (Dinophyceae) identified from Alaskan waters and a review of species-specific Alexandrium molecular assays.
Congenital Abnormalities
A meta-analysis of the pros and cons of partial superficial parotidectomy versus superficial parotidectomy for the treatment of benign parotid neoplasms.
Congenital Abnormalities
Anesthetic management of a patient with progressive supranuclear palsy.
Congenital Abnormalities
Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Congenital Abnormalities
Risk of Primary Spontaneous Pneumothorax According to Chest Configuration.
Contracture
Erratum to: Novel Report of Phosphoserine Phosphatase Deficiency in an Adult with Myeloneuropathy and Limb Contractures.
Contracture
Novel Report of Phosphoserine Phosphatase Deficiency in an Adult with Myeloneuropathy and Limb Contractures.
Corticobasal Degeneration
A combination of CSF tau ratio and midsaggital midbraintopons atrophy for the early diagnosis of progressive supranuclear palsy.
Corticobasal Degeneration
A novel diagnostic marker for progressive supranuclear palsy targeting atrophy of the subthalamic nucleus.
Corticobasal Degeneration
Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and Neuroprotection and Natural History in Parkinson Plus Syndromes Criteria for the Diagnosis of Progressive Supranuclear Palsy.
Corticobasal Degeneration
An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
Corticobasal Degeneration
Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
Corticobasal Degeneration
APOE ?2 is associated with increased tau pathology in primary tauopathy.
Corticobasal Degeneration
Applause sign in Parkinsonian disorders and Huntington's disease.
Corticobasal Degeneration
Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy.
Corticobasal Degeneration
Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies.
Corticobasal Degeneration
Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes.
Corticobasal Degeneration
Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.
Corticobasal Degeneration
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Corticobasal Degeneration
Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update.
Corticobasal Degeneration
Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy.
Corticobasal Degeneration
Cerebral peduncle angle: Unreliable in differentiating progressive supranuclear palsy from other neurodegenerative diseases.
Corticobasal Degeneration
Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders.
Corticobasal Degeneration
Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
Corticobasal Degeneration
Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.
Corticobasal Degeneration
Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report.
Corticobasal Degeneration
Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical parkinsonian disorders.
Corticobasal Degeneration
Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy.
Corticobasal Degeneration
CSF sAPP? and sAPP? levels in Alzheimer's Disease and Multiple Other Neurodegenerative Diseases: A Network Meta-Analysis.
Corticobasal Degeneration
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
Corticobasal Degeneration
Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats.
Corticobasal Degeneration
Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.
Corticobasal Degeneration
Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases.
Corticobasal Degeneration
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
Corticobasal Degeneration
Family history of frontotemporal lobar degeneration in Asia - an international multi-center research.
Corticobasal Degeneration
High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies.
Corticobasal Degeneration
Is brain perfusion a differentiating feature in the comparison of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)?
Corticobasal Degeneration
Late-onset Niemann-Pick disease type C overlapping with frontotemporal dementia syndromes: a case report.
Corticobasal Degeneration
Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.
Corticobasal Degeneration
Microtubule-associated protein tau genetic variations are uncommon cause of frontotemporal dementia in south India.
Corticobasal Degeneration
Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
Corticobasal Degeneration
Motor, cognitive and behavioral differences in MDS PSP phenotypes.
Corticobasal Degeneration
MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice.
Corticobasal Degeneration
MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome.
Corticobasal Degeneration
Neuronal correlates of clinical asymmetry in progressive supranuclear palsy.
Corticobasal Degeneration
Neuropathological comorbidity associated with argyrophilic grain disease.
Corticobasal Degeneration
Pathologic correlates of supranuclear gaze palsy with parkinsonism.
Corticobasal Degeneration
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy.
Corticobasal Degeneration
Preferential neurodegeneration in the cervical spinal cord of progressive supranuclear palsy.
Corticobasal Degeneration
Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD.
Corticobasal Degeneration
Profound degeneration of wake-promoting neurons in Alzheimer's disease.
Corticobasal Degeneration
Progressive supranuclear palsy presenting with hyperkinetic movement disorder and hemiplegic dystonia: a case report.
Corticobasal Degeneration
Progressive supranuclear palsy with fronto-temporal atrophy and various tau-positive abnormal structures.
Corticobasal Degeneration
Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
Corticobasal Degeneration
Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
Corticobasal Degeneration
Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms.
Corticobasal Degeneration
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy.
Corticobasal Degeneration
Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration.
Corticobasal Degeneration
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
Corticobasal Degeneration
The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.
Corticobasal Degeneration
The Relationship Between Development of Neuronal and Astrocytic Tau Pathologies in Subcortical Nuclei and Progression of Argyrophilic Grain Disease.
Corticobasal Degeneration
The Value of GRE, ADC and Routine MRI in Distinguishing Parkinsonian Disorders.
Corticobasal Degeneration
Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
Corticobasal Degeneration
Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies.
Corticobasal Degeneration
Ultrastructural characterization of the tau-immunoreactive tubules in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy.
Corticobasal Degeneration
Unexpected abundance of pathological tau in progressive supranuclear palsy white matter.
Corticobasal Degeneration
Untangling the tau gene association with neurodegenerative disorders.
Corticobasal Degeneration
Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
Corticobasal Degeneration
What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features?
Corticobasal Degeneration
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
Corticobasal Degeneration
Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Corticobasal Degeneration
[A 57-year-old woman with progressive disturbance of gait and mental deterioration]
Corticobasal Degeneration
[A 62-year-old Woman Presenting with Progressive Nonfluent Aphasia, Apraxia of Eyelid Opening, Supranuclear Gaze Palsy, and Asymmetric Rigidity].
Corticobasal Degeneration
[A 68-year-old man with speech disturbance as the initial symptom followed by bradykinesia and dementia. Clinical conference]
Corticobasal Degeneration
[Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report].
Corticobasal Degeneration
[The application of Gallyas-Braak stainings in pathologic diagnosis of neurodegenerative diseases]
Cough
Analysis of the clinical differentiation of pulmonary sclerosing pneumocytoma and lung cancer.
Cough
Comparison of tracheal intubation with controlled ventilation and laryngeal mask airway with spontaneous ventilation for thoracoscopic bullectomy.
Cough
Cough reflex attenuation and swallowing dysfunction in sub-acute post-stroke patients: prevalence, risk factors, and clinical outcome.
Cough
Immediate Effects of Sensorimotor Training in Airway Protection (smTAP) on Cough Outcomes in Progressive Supranuclear Palsy: A Feasibility Study.
Cough
Sensorimotor Cough Dysfunction Is Prevalent and Pervasive in Progressive Supranuclear Palsy.
Cough
The Role of Vocal Fold Bowing on Cough and Swallowing Dysfunction in Progressive Supranuclear Palsy.
COVID-19
How Have Public Safety Personnel Seeking Digital Mental Healthcare Been Affected by the COVID-19 Pandemic? An Exploratory Mixed Methods Study.
Creutzfeldt-Jakob Syndrome
Creutzfeldt-Jakob disease presenting as progressive supranuclear palsy.
Crohn Disease
Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.
Cross Infection
[The use of data on the composition and drug resistance of the causative agents of suppuration in a retrospective analysis of the epidemiological situation in a hospital]
Cysts
Determination of paralytic shellfish toxins in Portuguese shellfish by automated pre-column oxidation.
Cysts
Dynamics of Alexandrium fundyense blooms and shellfish toxicity in the Nauset Marsh System of Cape Cod (Massachusetts, USA).
Cysts
Promoter methylation is not associated with FLCN irregulation in lung cyst lesions of primary spontaneous pneumothorax.
Cysts
Saxitoxin and neosaxitoxin as toxic principles of Alexandrium andersoni (Dinophyceae) from the Gulf of Naples, Italy.
Cysts
Source and profile of paralytic shellfish poisoning toxins in shellfish in Daya Bay, South China Sea.
Deglutition Disorders
A case of spinal anesthesia in a patient with progressive supranuclear palsy.
Deglutition Disorders
Case diagnosis and characterization of suspected paralytic shellfish poisoning in Alaska.
Deglutition Disorders
Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy.
Deglutition Disorders
Clinical Profile of Dysphagia in Patients with Parkinson's Disease, Progressive Supranuclear Palsy and Multiple System Atrophy.
Deglutition Disorders
Comparison of swallowing function in Parkinson's disease and progressive supranuclear palsy.
Deglutition Disorders
Cough reflex attenuation and swallowing dysfunction in sub-acute post-stroke patients: prevalence, risk factors, and clinical outcome.
Deglutition Disorders
Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy.
Deglutition Disorders
Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy.
Deglutition Disorders
Freezing of gait is an early clinical feature of progressive supranuclear palsy.
Deglutition Disorders
Health-related quality of life in patients with progressive supranuclear palsy.
Deglutition Disorders
Natural clinical course of progressive supranuclear palsy in Chinese patients in Hong Kong.
Deglutition Disorders
Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
Deglutition Disorders
Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis.
Deglutition Disorders
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders.
Deglutition Disorders
Risk factors for and impact of poststroke pneumonia in patients with acute ischemic stroke.
Deglutition Disorders
Usefulness of the Neutrophil-to-Lymphocyte Ratio as a Predictor of Pneumonia and Urinary Tract Infection Within the First Week After Acute Ischemic Stroke.
Deglutition Disorders
[A case of a syndrome resembling PSP after aortic arch replacement under deep hypothermic circulatory arrest].
Deglutition Disorders
[An assessment of dysphagia using videofluorography in Parkinson's disease and progressive supranuclear palsy]
Dehydration
Contribution of arbuscular mycorrhizal fungi and/or bacteria to enhancing plant drought tolerance under natural soil conditions: effectiveness of autochthonous or allochthonous strains.
Dementia
?-Synuclein in Plasma-Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease.
Dementia
A Novel MAPT Mutation, G55R, in a Frontotemporal Dementia Patient Leads to Altered Tau Function.
Dementia
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Dementia
Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias.
Dementia
Alpha-synuclein Levels in the Differential Diagnosis of Lewy Bodies Dementia and Other Neurodegenerative Disorders: A Meta-analysis.
Dementia
Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy.
Dementia
Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies.
Dementia
Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy.
Dementia
Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy.
Dementia
Brain dopamine transporter binding and glucose metabolism in progressive supranuclear palsy-like creutzfeldt-jakob disease.
Dementia
Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing.
Dementia
Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
Dementia
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
Dementia
Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study.
Dementia
Cognitive and behavioral aspects of PSP since Steele, Richardson and Olszewski's description of PSP 40 years ago and Albert's delineation of the subcortical dementia 30 years ago.
Dementia
Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia.
Dementia
Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease.
Dementia
Concentration of neural thread protein in cerebrospinal fluid from progressive supranuclear palsy and Parkinson's disease.
Dementia
Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline.
Dementia
Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy.
Dementia
CSF sAPP? and sAPP? levels in Alzheimer's Disease and Multiple Other Neurodegenerative Diseases: A Network Meta-Analysis.
Dementia
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
Dementia
Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank.
Dementia
Differentiation of PA from early PSP with different patterns of symptoms and CBF reduction.
Dementia
Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats.
Dementia
Disease course and treatment patterns in progressive supranuclear palsy: A real-world study.
Dementia
Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases.
Dementia
Familial aggregation in atypical Parkinson's disease: a case control study in multiple system atrophy and progressive supranuclear palsy.
Dementia
FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations.
Dementia
Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Dementia
How to spot ocular abnormalities in progressive supranuclear palsy? A practical review.
Dementia
Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series.
Dementia
It takes two to tango: carers' reflections on their participation and the participation of people with dementia in the James Lind Alliance process.
Dementia
Late-onset Niemann-Pick disease type C overlapping with frontotemporal dementia syndromes: a case report.
Dementia
Long leukocyte telomere length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism.
Dementia
Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.
Dementia
Microtubule-associated protein tau genetic variations are uncommon cause of frontotemporal dementia in south India.
Dementia
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy.
Dementia
Muscarinic receptors in the thalamus in progressive supranuclear palsy and other neurodegenerative disorders.
Dementia
Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome.
Dementia
Natural history of progressive supranuclear palsy: a clinicopathologic study from a population of brain donors.
Dementia
Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Dementia
Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP?
Dementia
Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders.
Dementia
Obsessive-compulsive behavior as a symptom of dementia in progressive supranuclear palsy.
Dementia
Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy.
Dementia
Post mortem cerebrospinal fluid ?-synuclein levels are raised in multiple system atrophy and distinguish this from the other ?-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
Dementia
Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology.
Dementia
Progressive supranuclear palsy combined with Alzheimer's disease: A clinicopathological study of two autopsy cases.
Dementia
Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like magnetic resonance imaging features.
Dementia
Progressive supranuclear palsy with fronto-temporal atrophy and various tau-positive abnormal structures.
Dementia
Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of parkinsonism-dementia complex of Guam but not alzheimer's disease or progressive supranuclear palsy.
Dementia
Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis.
Dementia
Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
Dementia
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy.
Dementia
Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models.
Dementia
The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases.
Dementia
The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy.
Dementia
The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease.
Dementia
Understanding the relationship between freezing of gait and other progressive supranuclear palsy features.
Dementia
Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Dementia
[A 57-year-old woman with progressive disturbance of gait and mental deterioration]
Dementia
[A 85-year-old woman with the onset of progressive gait disturbance at 80 years of the age]
Dementia
[An autopsy case of corticobasal degeneration without prominent cortical pathology--an imitator of progressive supranuclear palsy]
Dementia
[Cerebral blood flow and oxygen metabolism in patients with pure akinesia and progressive supranuclear palsy]
Dementia
[Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis]
Dementia
[Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of a case and review of the literature]
Demyelinating Diseases
Abnormal signals on proton density-weighted MRI of the superior cerebellar peduncle in progressive supranuclear palsy.
Depression, Postpartum
Supporting women with perinatal mental health problems: the role of the voluntary sector.
Diabetes Mellitus
Antidiabetic activity of a polysaccharide-protein complex from Asian Clam (Corbicula fluminea) in streptozotoxin-induced diabetic rats and its underlying mechanism.
Diabetes Mellitus
Black soybean tempeh and purple sweet potato improve sperm quality in streptozotocin-induced diabetic rats.
Diabetes Mellitus
Clinical Features Observed in General Practice Associated With the Subsequent Diagnosis of Progressive Supranuclear Palsy.
Diabetes Mellitus
Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2.
Diabetes Mellitus
Optimizing insulin initiation in primary care: the Diabetes CoStars patient support program.
Diabetes Mellitus
Polygonatum sibiricum polysaccharide potentially attenuates diabetic retinal injury in a diabetic rat model.
Diabetes Mellitus, Type 2
Optimizing insulin initiation in primary care: the Diabetes CoStars patient support program.
Diabetic Nephropathies
Immunological characterization of pancreatic stone protein in human urine.
Diabetic Nephropathies
Urinary excretion of pancreatic stone protein in diabetic nephropathy.
Diabetic Retinopathy
Polygonatum sibiricum polysaccharide inhibits high glucose-induced oxidative stress, inflammatory response, and apoptosis in RPE cells.
Disorders of Excessive Somnolence
Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study.
Drug-Related Side Effects and Adverse Reactions
Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off-Target Effects from Chemical Structure.
Dry Eye Syndromes
Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyes.
Dry Eye Syndromes
Prevalence of Novel Candidate Sjögren Syndrome Autoantibodies in the Penn Sjögren's International Collaborative Clinical Alliance Cohort.
Dry Socket
Persistent socket pain postenucleation and post evisceration: a systematic review.
Duodenogastric Reflux
Comparative inhibition of coffee-induced gastric acid secretion employing misoprostol and cimetidine.
Dysarthria
Case diagnosis and characterization of suspected paralytic shellfish poisoning in Alaska.
Dysarthria
Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
Dysarthria
Differentiation of PA from early PSP with different patterns of symptoms and CBF reduction.
Dysarthria
Distinct patterns of imprecise consonant articulation among Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Dysarthria
Effects of cerebellar neuromodulation in movement disorders: A systematic review.
Dysarthria
Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
Dysarthria
Freezing of gait is an early clinical feature of progressive supranuclear palsy.
Dysarthria
Major depressive disorder preceding the onset of progressive supranuclear palsy.
Dysarthria
Motor Speech Disorders and Communication Limitations in Progressive Supranuclear Palsy.
Dysarthria
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders.
Dysarthria
Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Dysarthria
Trial of Zolpidem, Eszopiclone, and Other GABA Agonists in a Patient with Progressive Supranuclear Palsy.
Dyskinesias
Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease.
Dyskinesias
Effects of cerebellar neuromodulation in movement disorders: A systematic review.
Dyskinesias
Levodopa responsiveness in disorders with parkinsonism: a review of the literature.
Dyskinesias
Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
Dyspareunia
The clinical features and management of perineal endometriosis with anal sphincter involvement: a clinical analysis of 31 cases.
Dyspnea
Bilateral primary spontaneous pneumothorax with multiple bleb performed by VATS and wedge resection: A rare case in Indonesian adult and review article.
Dystonia
Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia.
Dystonia
Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration.
Dystonia
Comparison of dystonia between Parkinson's disease and atypical parkinsonism: The clinical usefulness of dystonia distribution and characteristics in the differential diagnosis of parkinsonism.
Dystonia
Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Dystonia
Laryngeal dystonia causing upper airway obstruction in progressive supranuclear palsy.
Dystonia
Nocturnal manifestations of atypical and vascular parkinsonism: How do they differ from Parkinson's disease?
Dystonia
Progressive supranuclear palsy presenting with hyperkinetic movement disorder and hemiplegic dystonia: a case report.
Dystonia
Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia.
Dystonia
[A case of a syndrome resembling PSP after aortic arch replacement under deep hypothermic circulatory arrest].
Dystonia
[An assessment of dysphagia using videofluorography in Parkinson's disease and progressive supranuclear palsy]
Dystonia
[Dopaminergic drug-induced jaw-opening dystonia in a patient with progressive supranuclear palsy].
Dystonia
[Widespread argentophilic structures in progressive supranuclear palsy--an autopsy case report]
Dystonic Disorders
Progressive supranuclear palsy: report of a case with torticollis, blepharospasm, and dysfluency.
Echolalia
Case Report: Barely Able to Speak, Can't Stop Echoing: Echolalic Dynamic Aphasia in Progressive Supranuclear Palsy.
Encephalitis
[A 85-year-old woman with the onset of progressive gait disturbance at 80 years of the age]
Encephalitis, Arbovirus
Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism?
Endometrial Neoplasms
Membrane-associated serine/threonine protein phosphatase in endometrial cancer.
Epiretinal Membrane
Perisilicone proliferation after vitrectomy for proliferative vitreoretinopathy.
Erythema Infectiosum
Detection of IgE anti-parvovirus B19 and increased CD23+ B cells in parvovirus B19 infection: relation to Th2 cytokines.
Esophageal Achalasia
Full-layer mucosal histology in achalasia: Histological epithelial wave is characteristic in "pinstripe pattern"-positive achalasia.
Esophageal Neoplasms
A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae).
Essential Tremor
Enlargements of somatosensory-evoked potentials in progressive supranuclear palsy.
Essential Tremor
Obsessive compulsive personality disorder in Progressive Supranuclear Palsy, Multiple System Atrophy and Essential Tremor.
Essential Tremor
The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using 11C-2-beta-carbomethoxy-3-beta-(4-fluorophenyl)-tropane in patients with movement disorders.
Essential Tremor
Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects.
Facial Nerve Injuries
Superficial parotidectomy versus retrograde partial superficial parotidectomy in treating benign salivary gland tumor (pleomorphic adenoma).
Febrile Neutropenia
Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropenia.
Fecal Incontinence
The clinical features and management of perineal endometriosis with anal sphincter involvement: a clinical analysis of 31 cases.
Fetal Death
Perinatal and infant outcomes of prenatal diagnosis of heterotaxy syndrome (asplenia and polysplenia).
Foodborne Diseases
Measurements of paralytic shellfish poisons. A review of biological and chemical procedures.
Foodborne Diseases
Saxitoxin puffer fish poisoning in the United States, with the first report of Pyrodinium bahamense as the putative toxin source.
Foodborne Diseases
Simultaneous determination of twelve paralytic shellfish poisoning toxins in bivalve molluscs by UPLC-MS/MS and its applications to a food poisoning incident.
Foot Deformities
Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Frontotemporal Dementia
A combination of CSF tau ratio and midsaggital midbraintopons atrophy for the early diagnosis of progressive supranuclear palsy.
Frontotemporal Dementia
A Novel MAPT Mutation, G55R, in a Frontotemporal Dementia Patient Leads to Altered Tau Function.
Frontotemporal Dementia
Applause sign: is it really specific for Parkinsonian disorders? Evidence from cortical dementias.
Frontotemporal Dementia
Cognitive-behavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia.
Frontotemporal Dementia
Early and pre-symptomatic neuropsychological dysfunction in the PPND family with the N279K tau mutation.
Frontotemporal Dementia
Energization and spoken language production: Evidence from progressive supranuclear palsy.
Frontotemporal Dementia
Family history of frontotemporal lobar degeneration in Asia - an international multi-center research.
Frontotemporal Dementia
Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies.
Frontotemporal Dementia
Frontotemporal lobar degeneration (FTLD) concept and classification update.
Frontotemporal Dementia
FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations.
Frontotemporal Dementia
Further extension of the H1 haplotype associated with progressive supranuclear palsy.
Frontotemporal Dementia
Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Frontotemporal Dementia
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy.
Frontotemporal Dementia
Neurofibrillary tangle parkinsonian disorders--tau pathology and tau genetics.
Frontotemporal Dementia
Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Frontotemporal Dementia
Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic.
Frontotemporal Dementia
Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease.
Frontotemporal Dementia
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy.
Frontotemporal Dementia
Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies.
Frontotemporal Dementia
Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders.
Frontotemporal Dementia
Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD.
Frontotemporal Dementia
Progressive supranuclear palsy presenting with hyperkinetic movement disorder and hemiplegic dystonia: a case report.
Frontotemporal Dementia
Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
Frontotemporal Dementia
Sequence analysis of tau in familial and sporadic progressive supranuclear palsy.
Frontotemporal Dementia
Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases.
Frontotemporal Dementia
Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration.
Frontotemporal Dementia
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy.
Frontotemporal Dementia
Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy.
Frontotemporal Dementia
Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP.
Frontotemporal Dementia
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
Frontotemporal Dementia
The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias.
Frontotemporal Dementia
The tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases.
Frontotemporal Dementia
Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.
Frontotemporal Dementia
Untangling the tau gene association with neurodegenerative disorders.
Frontotemporal Dementia
[A clinical case of progressive supranuclear palsy with long-term frontal presentation preceding the onset of gaze palsy].
Frontotemporal Dementia
[Frontotemporal lobar degeneration (FTLD) - changes of its concept and classification based on aggregated proteins].
Frontotemporal Lobar Degeneration
An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
Frontotemporal Lobar Degeneration
Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS.
Frontotemporal Lobar Degeneration
Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?
Frontotemporal Lobar Degeneration
Biomarkers in frontotemporal lobar degenerations-Progress and challenges.
Frontotemporal Lobar Degeneration
Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology.
Frontotemporal Lobar Degeneration
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
Frontotemporal Lobar Degeneration
Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
Frontotemporal Lobar Degeneration
Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
Frontotemporal Lobar Degeneration
First symptom guides diagnosis and prognosis in neurodegenerative diseases-a retrospective study of autopsy proven cases.
Frontotemporal Lobar Degeneration
Frontotemporal lobar degeneration (FTLD) concept and classification update.
Frontotemporal Lobar Degeneration
Genetic pleiotropy and the shared pathological features of corticobasal degeneration and progressive supranuclear palsy: a case report and a review of the literature.
Frontotemporal Lobar Degeneration
High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies.
Frontotemporal Lobar Degeneration
Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Frontotemporal Lobar Degeneration
Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP.
Frontotemporal Lobar Degeneration
Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.
Frontotemporal Lobar Degeneration
New insights into biological markers of frontotemporal lobar degeneration spectrum.
Frontotemporal Lobar Degeneration
Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders.
Frontotemporal Lobar Degeneration
Non-Alzheimer's disease dementias: anatomic, clinical, and molecular correlates.
Frontotemporal Lobar Degeneration
Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease.
Frontotemporal Lobar Degeneration
Progressive modulation of the human olfactory bulb transcriptome during Alzheimer´s disease evolution: novel insights into the olfactory signaling across proteinopathies.
Frontotemporal Lobar Degeneration
Seizure prevalence in neurodegenerative diseases-a study of autopsy proven cases.
Frontotemporal Lobar Degeneration
Sensitivity-Specificity of Tau and Amyloid ? Positron Emission Tomography in Frontotemporal Lobar Degeneration.
Frontotemporal Lobar Degeneration
The olfactory bulb proteotype differs across frontotemporal dementia spectrum.
Frontotemporal Lobar Degeneration
[Frontotemporal lobar degeneration (FTLD) - changes of its concept and classification based on aggregated proteins].
Ganglioglioma
Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders.
Glioblastoma
219?Liquid Biopsy Can Distinguish Recurrent Glioblastomas From Pseudoprogression and Radiation Necrosis After Concurrent Radiochemotherapy.
Glioblastoma
A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma.
Glioblastoma
Can Tumor Location on Pre-treatment MRI Predict Likelihood of Pseudo-Progression vs. Tumor Recurrence in Glioblastoma?-A Feasibility Study.
Glioblastoma
Combined analysis of MGMT methylation and dynamic-susceptibility-contrast MRI for the distinction between early and pseudo-progression in glioblastoma patients.
Glioblastoma
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[(18)F]fluoroethyl)-L-tyrosine PET.
Glioblastoma
Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma.
Glioblastoma
Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiation.
Glioblastoma
Serine/threonine protein phosphatase 6 modulates the radiation sensitivity of glioblastoma.
Glioblastoma
Systemic siRNA delivery to tumors by cell-penetrating ?-helical polypeptide-based metastable nanoparticles.
Glioma
Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma.
Glioma
Differentiating high-grade glioma recurrence from pseudoprogression: Comparing diffusion kurtosis imaging and diffusion tensor imaging.
Glioma
Evaluation of polysaccharopeptide effects against C6 glioma in combination with radiation.
Glioma
Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.
Glioma
Meta-analysis of the diagnostic performance of diffusion magnetic resonance imaging with apparent diffusion coefficient measurements for differentiating glioma recurrence from pseudoprogression.
Glioma
Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.
Glioma
The value of MGMT promote methylation and IDH-1 mutation on diagnosis of pseudoprogression in patients with high-grade glioma: A meta-analysis.
Hallucinations
Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Hallucinations
Hydrocephalic Parkinsonism: lessons from normal pressure hydrocephalus mimics.
Hallucinations
Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: A prospective study.
Hallucinations
Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.
HELLP Syndrome
[Hepatic Rupture as a Complication of Hypertensive Disease of Pregnancy Maternal and the HELLP Syndrome]
Hemangiosarcoma
Single agent polysaccharopeptide delays metastases and improves survival in naturally occurring hemangiosarcoma.
Hematuria
In vitro immunoglobulin production by peripheral blood mononuclear cells as a prognostic factor in IgA nephropathy.
Hemothorax
The effect of pleural abrasion on the treatment of primary spontaneous pneumothorax: a systematic review of randomized controlled trials.
Hepatitis
Intake of purple sweet potato beverage affects on serum hepatic biomarker levels of healthy adult men with borderline hepatitis.
Hepatitis
Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China.
Herpes Simplex
Detection of herpes simplex virus and adenovirus DNA by dot blot hybridization using in vitro synthesized RNA transcripts.
Herpes Zoster
Aggregated and monomeric forms of proteins in boar seminal plasma: characterization and binding properties.
Hidradenitis
Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.
HIV Infections
Reversible progressive supranuclear palsy-like phenotype as an initial manifestation of HIV infection.
Huntington Disease
Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders.
Huntington Disease
The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy.
Hydrocephalus
Hydrocephalic Parkinsonism: lessons from normal pressure hydrocephalus mimics.
Hydrocephalus
Magnetic Resonance Imaging Biomarkers Distinguish Normal Pressure Hydrocephalus From Progressive Supranuclear Palsy.
Hydrocephalus
Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses.
Hydrocephalus
Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like magnetic resonance imaging features.
Hydrocephalus
The in vitro evaluation of the PSP and indigo carmine tests for obstruction in hydrocephalus.
Hydrocephalus
[Cerebrospinal fluid absorption mechanism--based on measurement of CSF flow rate in shunt tube]
Hydrocephalus, Normal Pressure
Hydrocephalic Parkinsonism: lessons from normal pressure hydrocephalus mimics.
Hydrocephalus, Normal Pressure
Magnetic Resonance Imaging Biomarkers Distinguish Normal Pressure Hydrocephalus From Progressive Supranuclear Palsy.
Hyperalgesia
Subcutaneous ?-Conotoxins Alleviate Mechanical Pain in Rodent Models of Acute Peripheral Neuropathy.
Hyperglycemia
Seed Proteomic Profiles of Three Paeonia Varieties and Evaluation of Peony Seed Protein as a Food Product.
Hyperhidrosis
Characterisation of pleural inflammation occurring after primary spontaneous pneumothorax.
Hyperkinesis
Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders.
Hyperkinesis
Progressive supranuclear palsy presenting with hyperkinetic movement disorder and hemiplegic dystonia: a case report.
Hyperlipidemias
Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China.
Hyperlipidemias
[Effect of polysaccharides from Polygonatum sibiricum on lipid-metabolism related mRNA and protein expression in hyperlipidemic mice].
Hypersensitivity
Dietary supplementation with mushroom-derived protein-bound glucan does not enhance immune function in young and old mice.
Hypersensitivity
Immune enhancement of a polysaccharides peptides isolated from Coriolus versicolor.
Hypersensitivity
Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherence.
Hypersensitivity
Use of the biventer cervicis nerve-muscle preparation to detect early changes following exposure to organophosphates inducing delayed neuropathy.
Hypertension
Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP).
Hypertension
In vitro immunoglobulin production by peripheral blood mononuclear cells as a prognostic factor in IgA nephropathy.
Hypertension
Relationship between postoperative blood pressure change and renal pathophysiology in primary aldosteronism.
Hypertension
Renal function studies in hypertension: with particular reference to the intravenous PSP test.
Hypertension
[Incidence, etiology and prognostic value of persistent significant proteinuria in kidney transplants]
Hypesthesia
Hypodipsia discriminates progressive supranuclear palsy from other parkinsonian syndromes.
Hypokinesia
Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale.
Hypokinesia
Clinical and dual-tasking aspects in frequent and infrequent fallers with progressive supranuclear palsy.
Hypokinesia
Coexistence of Progressive Supranuclear Palsy With Pontocerebellar Atrophy and Myotonic Dystrophy Type 1.
Hypokinesia
Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy.
Hypokinesia
Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Hypokinesia
Laboratory based assessment of gait and balance impairment in patients with progressive supranuclear palsy.
Hypokinesia
Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations.
Hypokinesia
Natural history and clinical features of progressive supranuclear palsy: a clinical study.
Hypokinesia
Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings.
Hypokinesia
Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options.
Hypokinesia
The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.
Hypokinesia
Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Hypokinesia
[An autopsy case of corticobasal degeneration without prominent cortical pathology--an imitator of progressive supranuclear palsy]
Hypokinesia
[Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of a case and review of the literature]
Hypotension, Orthostatic
Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy.
Hypotension, Orthostatic
Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension.
Hypotension, Orthostatic
Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia: Case report.
Hypothyroidism
Adult-onset hypothyroidism impairs paired-pulse facilitation and long-term potentiation of the rat dorsal hippocampo-medial prefrontal cortex pathway in vivo.
Immune System Diseases
Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherence.
Infections
A phagemid vector using the E. coli phage shock promoter facilitates phage display of toxic proteins.
Infections
A validation of presepsin levels in kidney dysfunction patients: four case reports.
Infections
Accuracy of pancreatic stone protein for the diagnosis of infection in hospitalized adults: a systematic review and individual patient level meta-analysis.
Infections
Analysis of the proteins and cis-acting elements regulating the stress-induced phage shock protein operon.
Infections
Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropenia.
Infections
Cerebrospinal Fluid Presepsin As a Marker of Nosocomial Infections of the Central Nervous System: A Prospective Observational Study.
Infections
Clinical application of presepsin as diagnostic biomarker of infection: overview and updates.
Infections
Detection of IgE anti-parvovirus B19 and increased CD23+ B cells in parvovirus B19 infection: relation to Th2 cytokines.
Infections
Effect of the endoparasite Amoebophrya sp. on toxin content and composition in the paralytic shellfish poisoning dinoflagellate Alexandrium fundyense (Dinophyceae).
Infections
Identification of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4-one derivatives as inhibitors of the phosphatase SerB653 in Porphyromonas gingivalis, implicated in periodontitis.
Infections
Leishmania donovani secretory serine protease alters macrophage inflammatory response via COX-2 mediated PGE-2 production.
Infections
Pancreatic stone protein and soluble CD25 for infection and sepsis in an emergency department.
Infections
Pancreatic stone protein predicts postoperative infection in cardiac surgery patients irrespective of cardiopulmonary bypass or surgical technique.
Infections
Pancreatic Stone Protein Predicts Sepsis in Severely Burned Patients Irrespective of Trauma Severity: A Monocentric Observational Study.
Infections
Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults: a case-control study.
Infections
Polysaccharide peptide from Coriolus versicolor induces interleukin 6-related extension of endotoxin fever in rats.
Infections
Prognostic value of flow cytometry in surgically treated primary gastric lymphoma.
Infections
Pseudomonas peritonitis in peritoneal dialysis patients: the Network #9 Peritonitis Study.
Infections
Regulation of the phage-shock-protein stress response in Yersinia enterocolitica.
Infections
Risk factors for and impact of poststroke pneumonia in patients with acute ischemic stroke.
Infections
Stress-induced expression of the Escherichia coli phage shock protein operon is dependent on sigma 54 and modulated by positive and negative feedback mechanisms.
Infections
The value of pancreatic stone protein in predicting acute appendicitis in patients presenting at the emergency department with abdominal pain.
Infections
Understanding the Impact of Drought on Foliar and Xylem Invading Bacterial Pathogen Stress in Chickpea.
Influenza, Human
Heterogeneous selective pressure acting on influenza B victoria- and yamagata-like hemagglutinins.
Insulin Resistance
Effects of calcineurin activation on insulin-, AICAR- and contraction-induced glucose transport in skeletal muscle.
Intellectual Disability
Phosphoserine phosphatase (PSPH) gene mutation in an intellectual disability family from Pakistan.
Ischemic Stroke
Post-stroke pneumonia at the stroke unit - a registry based analysis of contributing and protective factors.
Ischemic Stroke
Reduction of Neuromelanin-Positive Nigral Volume in Patients with MSA, PSP and CBD.
Ischemic Stroke
Risk factors for and impact of poststroke pneumonia in patients with acute ischemic stroke.
Ischemic Stroke
Risk stratification model for post-stroke pneumonia in patients with acute ischemic stroke.
Ischemic Stroke
[Vascular Wallerian degeneration on magnetic resonance in a patient with probable progressive supranuclear palsy: aetiology or casual link?]
Kidney Neoplasms
A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax.
Kidney Neoplasms
Novel in-frame deletion mutation in FLCN gene in a Korean family with recurrent primary spontaneous pneumothorax.
Language Disorders
Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy.
Language Disorders
Language Disorder in Progressive Supranuclear Palsy and Corticobasal Syndrome: Neural Correlates and Detection by the MLSE Screening Tool.
Leishmaniasis, Visceral
Leishmania donovani secretory serine protease alters macrophage inflammatory response via COX-2 mediated PGE-2 production.
Leukemia
A comparison of races and leukemia subtypes among patients in different cancer survivorship phases.
Leukemia
Augmentation of retinoic acid-induced granulocytic differentiation in HL-60 leukemia cells by serine/threonine protein phosphatase inhibitors.
Leukemia
Gossypol exerts its cytotoxic effect on HL-60 leukemic cell line via decreasing activity of protein phosphatase 2A and interacting with human telomerase reverse transcriptase activity.
Leukemia
Induction of S phase cell arrest and caspase activation by polysaccharide peptide isolated from Coriolus versicolor enhanced the cell cycle dependent activity and apoptotic cell death of doxorubicin and etoposide, but not cytarabine in HL-60 cells.
Leukemia
Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30.
Leukemia
Polysaccharopeptides derived from Coriolus versicolor potentiate the S-phase specific cytotoxicity of Camptothecin (CPT) on human leukemia HL-60 cells.
Leukemia
The cell death process of the anticancer agent polysaccharide-peptide (PSP) in human promyelocytic leukemic HL-60 cells.
Leukemia, Lymphocytic, Chronic, B-Cell
Trisomy 12 in chronic lymphocytic leukemia: an interphase cytogenetic study.
Leukemia, Myeloid
Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors.
Leukemia, T-Cell
Progressive spastic paraparesis associated with human T-cell leukemia virus type I (HTLV-I).
Leukocytosis
Progressive spastic paraparesis associated with human T-cell leukemia virus type I (HTLV-I).
Lewy Body Disease
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Lewy Body Disease
An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
Lewy Body Disease
Brain dopamine transporter binding and glucose metabolism in progressive supranuclear palsy-like creutzfeldt-jakob disease.
Lewy Body Disease
Cerebral peduncle angle: Unreliable in differentiating progressive supranuclear palsy from other neurodegenerative diseases.
Lewy Body Disease
Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.
Lewy Body Disease
Neurofibrillary tangles in the dentate granule cells of patients with Alzheimer's disease, Lewy body disease and progressive supranuclear palsy.
Lewy Body Disease
Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis.
Lewy Body Disease
Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension.
Lewy Body Disease
Regional brain atrophy in progressive supranuclear palsy and Lewy body disease.
Lewy Body Disease
Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes.
Lewy Body Disease
Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
Lewy Body Disease
Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Liver Cirrhosis
Assessing the permeability of the gastrointestinal mucosa after oral administration of phenolsulfonphthalein.
Liver Diseases
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection.
Liver Diseases
Influence of liver disease on phenolsulfonphthalein absorption from liver surface to examine possibility of direct liver surface application for drug targeting.
Liver Diseases
Proteoglycan isolated from Corbicula fluminea exerts hepato-protective effects against alcohol-induced liver injury in mice.
Liver Diseases
Significance of the peroral phenolsulfonphthalein test in hepatic resection: a possible predictor of bacterial translocation.
Liver Neoplasms
Enhancing the utility of Proteomics Signature Profiling (PSP) with Pathway Derived Subnets (PDSs), performance analysis and specialised ontologies.
Lordosis
Induction of pseudopregnancy using artificial VCS: importance of lordosis intensity and prestimulus estrous cycle length.
Lung Diseases
A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax.
Lung Diseases
Unilateral single-port thoracoscopic surgery for bilateral pneumothorax or pulmonary bullae.
Lung Neoplasms
A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae).
Lung Neoplasms
Analysis of the clinical differentiation of pulmonary sclerosing pneumocytoma and lung cancer.
Lung Neoplasms
Immunomodulatory effects of herbal formula of astragalus polysaccharide (APS) and polysaccharopeptide (PSP) in mice with lung cancer.
Lung Neoplasms
Large pulmonary sclerosing pneumocytoma with massive necrosis and vascular invasion: a case report.
Lung Neoplasms
Phosphoserine Phosphatase Promotes Lung Cancer Progression through the Dephosphorylation of IRS-1 and a Noncanonical L-Serine-Independent Pathway.
Lung Neoplasms
Polygonatum sibiricum polysaccharides play anti-cancer effect through TLR4-MAPK/NF-?B signaling pathways.
Lung Neoplasms
Pulmonary sclerosing pneumocytoma mimicking lung cancer: Case report and review of the literature.
Lung Neoplasms
Relevance of the rat lung tumor response to particle overload for human risk assessment-Update and interpretation of new data since ILSI 2000.
Lung Neoplasms
RHOB expression controls the activity of serine/threonine protein phosphatase PP2A to modulate mesenchymal phenotype and invasion in non-small cell lung cancers.
Lung Neoplasms
Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients.
Lymphatic Metastasis
Clinical and histopathologic features of pulmonary sclerosing pneumocytoma with dense spindle stromal cells and lymph node metastasis.
Lymphatic Metastasis
Large pulmonary sclerosing pneumocytoma with massive necrosis and vascular invasion: a case report.
Lymphatic Metastasis
Pulmonary sclerosing pneumocytoma with mediastinal lymph node metastasis: a case report.
Lymphatic Metastasis
[Resection of gastric carcinoma with preserving of the spleen and pancreas and functional clearance lymph nodes of the spleen hillus and splenic artery]
Lymphoma
Protective effect of polysaccharide peptide on cerebral ischemia?reperfusion injury in rats.
Lymphoma, B-Cell
Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma.
Machado-Joseph Disease
Hypertrophy of the inferior olivary nucleus in patients with progressive supranuclear palsy.
Macular Degeneration
Impact of a Patient Support Program on Patient Beliefs About Neovascular Age-Related Macular Degeneration and Persistence to Anti-Vascular Endothelial Growth Factor Therapy.
Macular Degeneration
[Progressive supranuclear palsy with macular degeneration--report of three cases]
Malaria
A novel tetratricopeptide repeat (TPR) containing PP5 serine/threonine protein phosphatase in the malaria parasite, Plasmodium falciparum.
Malaria
Characterisation and expression of a PP1 serine/threonine protein phosphatase (PfPP1) from the malaria parasite, Plasmodium falciparum: demonstration of its essential role using RNA interference.
Malaria
Characterization of a novel serine/threonine protein phosphatase (PfPPJ) from the malaria parasite, Plasmodium falciparum.
Mania
Self-Reported Graphic Personal and Social Performance Scale (SRG-PSP) for measuring functionality in patients with bipolar disorder.
Melanoma
PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1.
Memory Disorders
Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease.
Migraine Disorders
Menstrual migraine: a possible pathogenic implication of platelet function.
Miller Fisher Syndrome
[Clinical analysis of paralytic shellfish poisoning following ingestion of oysters]
Motor Neuron Disease
Family history of frontotemporal lobar degeneration in Asia - an international multi-center research.
Motor Neuron Disease
Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group.
Motor Neuron Disease
Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.
Motor Neuron Disease
Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia.
Motor Neuron Disease
Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
Motor Neuron Disease
The analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism.
Movement Disorders
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.
Movement Disorders
An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant.
Movement Disorders
Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
Movement Disorders
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.
Movement Disorders
Association of Tripartite Motif Containing 11 rs564309 with Tau Pathology in Progressive Supranuclear Palsy.
Movement Disorders
Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study.
Movement Disorders
Clinical Correlation Between Vertical Gaze Palsy and Midbrain Volume in Progressive Supranuclear Palsy.
Movement Disorders
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
Movement Disorders
Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study.
Movement Disorders
Clinimetric Analysis of the Motor Section of the Progressive Supranuclear Palsy Rating Scale: Reliability and Factor Analysis.
Movement Disorders
Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study.
Movement Disorders
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
Movement Disorders
Disease course and treatment patterns in progressive supranuclear palsy: A real-world study.
Movement Disorders
Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease.
Movement Disorders
Enlargements of somatosensory-evoked potentials in progressive supranuclear palsy.
Movement Disorders
Environmental and Occupational Risk Factors for Progressive Supranuclear Palsy: Case-Control Study.
Movement Disorders
Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study.
Movement Disorders
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study.
Movement Disorders
Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy.
Movement Disorders
Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from Parkinson plus syndromes.
Movement Disorders
Hypodipsia discriminates progressive supranuclear palsy from other parkinsonian syndromes.
Movement Disorders
In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism.
Movement Disorders
Is the Latency from Progressive Supranuclear Palsy Onset to Diagnosis Improving?
Movement Disorders
Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Movement Disorders
Long lasting pure freezing of gait preceding progressive supranuclear palsy: A clinicopathological study.
Movement Disorders
Longitudinal magnetic resonance imaging in progressive supranuclear palsy: A new combined score for clinical trials.
Movement Disorders
Midbrain/pons area ratio and clinical features predict the prognosis of progressive Supranuclear palsy.
Movement Disorders
MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy.
Movement Disorders
Multimodal Magnetic Resonance Imaging Quantification of Brain Changes in Progressive Supranuclear Palsy.
Movement Disorders
Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease.
Movement Disorders
Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP?
Movement Disorders
Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders.
Movement Disorders
Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic.
Movement Disorders
Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy.
Movement Disorders
Patient and care partner views on exercise and structured physical activity for people with Progressive Supranuclear Palsy.
Movement Disorders
PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes.
Movement Disorders
Preclinical, Phase I, and phase II investigational clinical trials for treatment of progressive supranuclear palsy.
Movement Disorders
Progression of gait, speech and swallowing deficits in progressive supranuclear palsy.
Movement Disorders
Progressive supranuclear palsy and idiopathic Parkinson's disease are associated with local reduction of in vivo brain viscoelasticity.
Movement Disorders
Progressive supranuclear palsy presenting with hyperkinetic movement disorder and hemiplegic dystonia: a case report.
Movement Disorders
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy.
Movement Disorders
Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
Movement Disorders
Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
Movement Disorders
Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration.
Movement Disorders
Thalamic stimulation-evoked sensations in chronic pain patients and in nonpain (movement disorder) patients.
Movement Disorders
The diagnosis of progressive supranuclear palsy: current opinions and challenges.
Movement Disorders
The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using 11C-2-beta-carbomethoxy-3-beta-(4-fluorophenyl)-tropane in patients with movement disorders.
Movement Disorders
The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases.
Movement Disorders
Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial.
Movement Disorders
Validation of the Italian version of carers' quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy.
Movement Disorders
Validation of the Italian version of the PSP Quality of Life questionnaire.
Multiple System Atrophy
A novel diagnostic marker for progressive supranuclear palsy targeting atrophy of the subthalamic nucleus.
Multiple System Atrophy
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Multiple System Atrophy
Amantadine-induced myoclonus in a patient with progressive supranuclear palsy.
Multiple System Atrophy
Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes.
Multiple System Atrophy
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Multiple System Atrophy
Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia.
Multiple System Atrophy
Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing.
Multiple System Atrophy
Central nystagmus in progressive supranuclear palsy: A neglected clinical feature?
Multiple System Atrophy
Clinical analysis of blepharospasm and apraxia of eyelid opening in patients with parkinsonism.
Multiple System Atrophy
Coexistence of PSP and MSA: a case report and review of the literature.
Multiple System Atrophy
Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes.
Multiple System Atrophy
Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
Multiple System Atrophy
Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy.
Multiple System Atrophy
Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism.
Multiple System Atrophy
Differentiating PSP from MSA using MR planimetric measurements: a systematic review and meta-analysis.
Multiple System Atrophy
Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium.
Multiple System Atrophy
Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy.
Multiple System Atrophy
Enteric GFAP expression and phosphorylation in Parkinson's disease.
Multiple System Atrophy
Eye movement deficits in X-linked dystonia-parkinsonism are related to striatal degeneration.
Multiple System Atrophy
Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Multiple System Atrophy
Lewy bodies in progressive supranuclear palsy represent an independent disease process.
Multiple System Atrophy
Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy.
Multiple System Atrophy
Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.
Multiple System Atrophy
Midbrain atrophy related to parkinsonism in a non-coding repeat expansion disorder: five cases of spinocerebellar ataxia type 31 with nigrostriatal dopaminergic dysfunction.
Multiple System Atrophy
Morning glory sign: a particular MR finding in progressive supranuclear palsy.
Multiple System Atrophy
MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects.
Multiple System Atrophy
Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome.
Multiple System Atrophy
Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
Multiple System Atrophy
Neuromelanin-sensitive magnetic resonance imaging in disease differentiation for parkinsonism or neurodegenerative disease affecting the basal ganglia.
Multiple System Atrophy
Obsessive compulsive personality disorder in Progressive Supranuclear Palsy, Multiple System Atrophy and Essential Tremor.
Multiple System Atrophy
Pathologic correlates of supranuclear gaze palsy with parkinsonism.
Multiple System Atrophy
Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Multiple System Atrophy
Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study.
Multiple System Atrophy
Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.
Multiple System Atrophy
Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.
Multiple System Atrophy
Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension.
Multiple System Atrophy
Progressive supranuclear palsy presenting with urinary retention and sleep apnea.
Multiple System Atrophy
Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy.
Multiple System Atrophy
Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Multiple System Atrophy
The contribution of trigemino-cervical reflexes in distinguishing progressive supranuclear palsy from multiple system atrophy.
Multiple System Atrophy
The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease.
Multiple System Atrophy
Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
Multiple System Atrophy
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
Multiple System Atrophy
[A case of progressive supranuclear palsy associated with bilateral vocal cord abductor paralysis]
Multiple System Atrophy
[An autopsy case of progressive supranuclear palsy with central pontine myelinolysis]
Multiple System Atrophy
[The application of Gallyas-Braak stainings in pathologic diagnosis of neurodegenerative diseases]
Muscle Cramp
Nocturnal manifestations of atypical and vascular parkinsonism: How do they differ from Parkinson's disease?
Muscle Rigidity
[Cerebral blood flow and oxygen metabolism in patients with pure akinesia and progressive supranuclear palsy]
Muscle Spasticity
Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
Muscle Spasticity
Perceptual analysis of speech disorders in progressive supranuclear palsy.
Muscle Spasticity
Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Myasthenia Gravis
[Clinical analysis of paralytic shellfish poisoning following ingestion of oysters]
Mycoses
Clinical application of presepsin as diagnostic biomarker of infection: overview and updates.
Mycoses
Toll recognition signal activates oenocytoid cell lysis via a crosstalk between plasmatocyte-spreading peptide and eicosanoids in response to a fungal infection.
Myeloproliferative Disorders
Gene dosage effect in acquired monosomy 7: distinct behaviour of beta-glucuronidase and phosphoserine phosphatase.
Myocardial Infarction
Presepsin (sCD14-ST): could it be a novel marker for the diagnosis of ST elevation myocardial infarction?
Myotonic Dystrophy
Coexistence of Progressive Supranuclear Palsy With Pontocerebellar Atrophy and Myotonic Dystrophy Type 1.
Myotonic Dystrophy
Tau-positive fine granules in the cerebral white matter: a novel finding among the tauopathies exclusive to parkinsonism-dementia complex of Guam.
Nasopharyngeal Carcinoma
A targeted nanocarrier based on polyspermine for the effective delivery of methotrexate in nasopharyngeal carcinoma.
Neonatal Sepsis
The Role of Pancreatic Stone Protein in Diagnosis of Early Onset Neonatal Sepsis.
Neoplasm Metastasis
Benign tumor behaves malignantly: a case report of bilateral multiple pulmonary sclerosing pneumocytoma.
Neoplasm Metastasis
Case Report: Rare Pulmonary Sclerosing Pneumocytoma: Large, Multiple, Metastatic, and Fatal.
Neoplasm Metastasis
Clinical and histopathologic features of pulmonary sclerosing pneumocytoma with dense spindle stromal cells and lymph node metastasis.
Neoplasm Metastasis
Fluoroscopy-Guided Percutaneous Sacroplasty for Painful Metastases at the Sacral Ala.
Neoplasm Metastasis
Large pulmonary sclerosing pneumocytoma with massive necrosis and vascular invasion: a case report.
Neoplasm Metastasis
Percutaneous Sacroplasty for Painful Sacral Metastases Involving Multiple Sacral Vertebral Bodies: Initial Experience with an Interpedicular Approach.
Neoplasm Metastasis
Pulmonary sclerosing pneumocytoma with mediastinal lymph node metastasis: a case report.
Neoplasm Metastasis
Radiation necrosis presenting as pseudoprogression (PsP) during alectinib treatment of previously radiated brain metastases in ALK-positive NSCLC: Implications for disease assessment and management.
Neoplasm Metastasis
Single agent polysaccharopeptide delays metastases and improves survival in naturally occurring hemangiosarcoma.
Neoplasm Metastasis
Understanding symptomatic experience, impact, and emotional response in recently diagnosed metastatic castration-resistant prostate cancer: a qualitative study.
Neoplasm Metastasis
[Resection of gastric carcinoma with preserving of the spleen and pancreas and functional clearance lymph nodes of the spleen hillus and splenic artery]
Neoplasms
A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax.
Neoplasms
A case of pulmonary sclerosing pneumocytoma diagnosed preoperatively using transbronchial cryobiopsy.
Neoplasms
A meta-analysis of the pros and cons of partial superficial parotidectomy versus superficial parotidectomy for the treatment of benign parotid neoplasms.
Neoplasms
A murine preclinical syngeneic transplantation model for breast cancer precision medicine.
Neoplasms
A photo-responsive peptide- and asparagine-glycine-arginine (NGR) peptide-mediated liposomal delivery system.
Neoplasms
A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma.
Neoplasms
A Retrospective Case-Control Study on the Chest Wall and Lung Characteristics in Patients with Primary Spontaneous Pneumothorax.
Neoplasms
A study on immunomodulatory mechanism of Polysaccharopeptide mediated by TLR4 signaling pathway.
Neoplasms
Activation of peritoneal macrophages by polysaccharopeptide from the mushroom, Coriolus versicolor.
Neoplasms
Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma.
Neoplasms
Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma.
Neoplasms
Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropenia.
Neoplasms
Antioxidant, Antityrosinase and Antitumor Activity Comparison: The Potential Utilization of Fibrous Root Part of Bletilla striata (Thunb.) Reichb.f.
Neoplasms
Can Tumor Location on Pre-treatment MRI Predict Likelihood of Pseudo-Progression vs. Tumor Recurrence in Glioblastoma?-A Feasibility Study.
Neoplasms
Case Report: Rare Pulmonary Sclerosing Pneumocytoma: Large, Multiple, Metastatic, and Fatal.
Neoplasms
Cell cycle-independent regulation of p21Waf1/Cip1 and retinoblastoma protein during okadaic acid-induced apoptosis is coupled with induction of Bax protein in human breast carcinoma cells.
Neoplasms
Characterization and Immunological Activities of Polysaccharides from Polygonatum sibiricum.
Neoplasms
Chemo- and radio-protective effects of polysaccharide of Spirulina platensis on hemopoietic system of mice and dogs.
Neoplasms
Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population.
Neoplasms
Clinical features in association with neurodegenerative diseases and malignancies.
Neoplasms
Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET.
Neoplasms
cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions.
Neoplasms
Comparison of postoperative complications and facial nerve recovery rates after conventional and partial superficial parotidectomy of benign parotid tumours: a prospective study.
Neoplasms
Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma.
Neoplasms
Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer.
Neoplasms
DC-AL GAN: Pseudoprogression and true tumor progression of glioblastoma multiform image classification based on DCGAN and AlexNet.
Neoplasms
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[(18)F]fluoroethyl)-L-tyrosine PET.
Neoplasms
Differences in association of the serine/threonine protein phosphatase PP-2A with microtubules of metastatic and nonmetastatic tumor cells.
Neoplasms
Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features.
Neoplasms
Dose-response and threshold analysis of tumor prevalence after intratracheal instillation of six types of low- and high-surface-area particles in a chronic rat experiment.
Neoplasms
Downregulation of CPI-17 contributes to dysfunctional motility in chronic intestinal inflammation model mice and ulcerative colitis patients.
Neoplasms
Effects of polysaccharide peptide (PSP) from Coriolus versicolor on the pharmacokinetics of cyclophosphamide in the rat and cytotoxicity in HepG2 cells.
Neoplasms
Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands.
Neoplasms
Enzyme pathology and the histologic categorization of human lung tumors: the continuum of quantitative biochemical indices of neoplasticity.
Neoplasms
Enzymic composition and growth rate of human pleural mesothelioma transplants in nude mice.
Neoplasms
Estrogen regulation of phosphoserine phosphatase during regression and recrudescence of female reproductive organs.
Neoplasms
Evaluation of polysaccharopeptide effects against C6 glioma in combination with radiation.
Neoplasms
Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.
Neoplasms
Genome profile in a extremely rare case of pulmonary sclerosing pneumocytoma presenting with diffusely-scattered nodules in the right lung.
Neoplasms
Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns?
Neoplasms
Huge Pulmonary Sclerosing Pneumocytoma with Endobronchial Invasion: A Case Report with a Literature Review.
Neoplasms
Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes.
Neoplasms
Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study.
Neoplasms
Immunomodulatory Properties of Coriolus versicolor: The Role of Polysaccharopeptide.
Neoplasms
Immunoregulatory and Anti-Tumor Effects of Polysaccharopeptide and Astragalus polysaccharides on Tumor-Bearing Mice.
Neoplasms
Immunostimulatory Effects of Polysaccharides from Spirulina platensis In Vivo and Vitro and Their Activation Mechanism on RAW246.7 Macrophages.
Neoplasms
Immunotherapy with low-dose interleukin-2 and a polysaccharopeptide derived from Coriolus versicolor.
Neoplasms
Inhibition of phosphoserine phosphatase enhances the anticancer efficacy of 5-fluorouracil in colorectal cancer.
Neoplasms
Inhibitory effects of polysaccharide extract from Spirulina platensis on corneal neovascularization.
Neoplasms
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.
Neoplasms
Modulation of antipyrine clearance by polysaccharide peptide (PSP) isolated from Coriolus versicolor in the rat.
Neoplasms
Molecular and histologic characteristics of pseudoprogression in diffuse gliomas.
Neoplasms
Molecular characterization of Coriolus versicolor PSP-induced apoptosis in human promyelotic leukemic HL-60 cells using cDNA microarray.
Neoplasms
Monitoring hydrogen polysulfide during ferroptosis with a two-photon fluorescent probe.
Neoplasms
Peptide-enhanced tumor accumulation of upconversion nanoparticles for sensitive upconversion luminescence/magnetic resonance dual-mode bioimaging of colorectal tumors.
Neoplasms
Peptide-Induced Self-Assembly of Therapeutics into a Well-Defined Nanoshell with Tumor-Triggered Shape and Charge Switch.
Neoplasms
Persistent socket pain postenucleation and post evisceration: a systematic review.
Neoplasms
Phosphatase magnesium-dependent 1 ? (PPM1D), serine/threonine protein phosphatase and novel pharmacological target in cancer.
Neoplasms
Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer.
Neoplasms
PI3K/Akt mediates expression of TNF-alpha mRNA and activation of NF-kappaB in calyculin A-treated primary osteoblasts.
Neoplasms
Pleomorphic adenoma: extracapsular dissection versus partial superficial parotidectomy with facial nerve dissection.
Neoplasms
Pleural granuloma mimicking malignancy 42 years after slurry talc injection for primary spontaneous pneumothorax.
Neoplasms
Polygonatum sibiricum polysaccharides play anti-cancer effect through TLR4-MAPK/NF-?B signaling pathways.
Neoplasms
Polysaccharide peptide (PSP) restores immunosuppression induced by cyclophosphamide in rats.
Neoplasms
Polysaccharide peptide from Coriolus versicolor induces interleukin 6-related extension of endotoxin fever in rats.
Neoplasms
Polysaccharide peptides from COV-1 strain of Coriolus versicolor induce hyperalgesia via inflammatory mediator release in the mouse.
Neoplasms
Polysaccharopeptide enhanced the anti-cancer effect of gamma-tocotrienol through activation of AMPK.
Neoplasms
Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30.
Neoplasms
Polysaccharopeptide exerts immunoregulatory effects via MyD88-dependent signaling pathway.
Neoplasms
Polysaccharopeptides derived from Coriolus versicolor potentiate the S-phase specific cytotoxicity of Camptothecin (CPT) on human leukemia HL-60 cells.
Neoplasms
Positive Resection Margins Detected by Standardized Study of a Pancreaticoduodenectomy Sample: Is There Any Real Impact on Long-term Survival?
Neoplasms
Potential impact of the Affordable Care Act's preventive services provision on breast cancer stage: A preliminary assessment.
Neoplasms
Potential of a novel polysaccharide preparation (GLPP) from Anhui-grown Ganoderma lucidum in tumor treatment and immunostimulation.
Neoplasms
Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China.
Neoplasms
Primary spontaneous pneumothorax in children: factors predicting recurrence and contralateral occurrence.
Neoplasms
Prognostic value of flow cytometry in surgically treated primary gastric lymphoma.
Neoplasms
PSP activates monocytes in resting human peripheral blood mononuclear cells: Immunomodulatory implications for cancer treatment.
Neoplasms
PSPH induces cell autophagy and promotes cell proliferation and invasion in the hepatocellular carcinoma cell line Huh7 via the AMPK/mTOR/ULK1 signaling pathway.
Neoplasms
PSPH Mediates the Metastasis and Proliferation of Non-small Cell Lung Cancer through MAPK Signaling Pathways.
Neoplasms
Pulmonary sclerosing pneumocytoma in an 18-year-old male patient: A case report and literature review.
Neoplasms
Recent Advances and Challenges in Studies of Control of Cancer Stem Cells and the Gut Microbiome by the Trametes-Derived Polysaccharopeptide PSP (Review).
Neoplasms
Relationships of parathyroid hormone, parathyroid secretory protein, parathyroid hormone messenger RNA, parathyroid secretory protein mRNA, and replication in human parathyroid adenoma and secondary hyperplasia tissues and cultures.
Neoplasms
Relevance of the rat lung tumor response to particle overload for human risk assessment-Update and interpretation of new data since ILSI 2000.
Neoplasms
Review of surgical techniques and guide for decision making in the treatment of benign parotid tumors.
Neoplasms
Single agent polysaccharopeptide delays metastases and improves survival in naturally occurring hemangiosarcoma.
Neoplasms
Surgical interventions for management of benign parotid tumors: A systematic review and network meta-analysis.
Neoplasms
Systemic siRNA delivery to tumors by cell-penetrating ?-helical polypeptide-based metastable nanoparticles.
Neoplasms
Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment.
Neoplasms
The cell death process of the anticancer agent polysaccharide-peptide (PSP) in human promyelocytic leukemic HL-60 cells.
Neoplasms
The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma.
Neoplasms
The proximal serrated polyp detection rate is an easy-to-measure proxy for the detection rate of clinically relevant serrated polyps.
Neoplasms
The value of MGMT promote methylation and IDH-1 mutation on diagnosis of pseudoprogression in patients with high-grade glioma: A meta-analysis.
Neoplasms
Thrombotic thrombocytopenic purpura associated with clopidogrel: further evaluation.
Neoplasms
Trametes versicolor (Synn. Coriolus versicolor) Polysaccharides in Cancer Therapy: Targets and Efficacy.
Neoplasms
Update of the Swedish Two-County Trial of breast cancer screening: histologic grade-specific and age-specific results.
Neoplasms
Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients.
Neoplasms
[Analysis of Clinical Characteristics of 35 Cases ?of Pulmonary Sclerosing Pneumocytoma].
Neoplasms
[Effect of polysaccharide from Spirulina platensis on hematopoietic cells proliferation, apoptosis and Bcl-2 expression in mice bearing tumor treated with chemotherapy]
Neoplasms
[Immunoregulatory activity of polysaccharopeptide and astragalus polysaccharides on EAC tumor-bearing mice]
Neoplasms
[Partial superficial parotidectomy versus superficial parotidectomy for treatment of parotid benign tumors: evidence-based medicine analysis].
Neoplasms
[Retrospective study of partial superficial parotidectomy and superficial parotidectomy on superficial parotid benign tumor].
Nephritis
[Clinico-biochemical study of experimental renal injuries in rats. 3. Relations between serum half-life of phenolsulfonphthalein and renal injuries]
Nervous System Diseases
A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy.
Nervous System Diseases
A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.
Nervous System Diseases
Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and Neuroprotection and Natural History in Parkinson Plus Syndromes Criteria for the Diagnosis of Progressive Supranuclear Palsy.
Nervous System Diseases
Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
Nervous System Diseases
Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis.
Nervous System Diseases
Characterizing swallowing abnormalities in progressive supranuclear palsy.
Nervous System Diseases
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
Nervous System Diseases
Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study.
Nervous System Diseases
Clinical heterogeneity in progressive supranuclear palsy: Problems of clinical diagnostic criteria of NINDS-SPSP in a retrospective study of seven Japanese autopsy cases.
Nervous System Diseases
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
Nervous System Diseases
Correlation between qualitative balance indices, dynamic posturography and structural brain imaging in patients with progressive supranuclear palsy and its subtypes.
Nervous System Diseases
Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
Nervous System Diseases
Diagnostic validity of magnetic resonance parkinsonism index in differentiating patients with progressive supranuclear palsy from patients with Parkinson's disease.
Nervous System Diseases
Familial aggregation of parkinsonism in progressive supranuclear palsy.
Nervous System Diseases
Freezing of gait is an early clinical feature of progressive supranuclear palsy.
Nervous System Diseases
Lack of association between progressive supranuclear palsy and arterial hypertension: a clinicopathological study.
Nervous System Diseases
Neurodegenerative disorders mimicking progressive supranuclear palsy: a report of three cases.
Nervous System Diseases
Phenotypic Variants of Patients with Progressive Supranuclear Palsy.
Nervous System Diseases
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).
Nervous System Diseases
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders.
Nervous System Diseases
Progression of falls in postmortem-confirmed parkinsonian disorders.
Nervous System Diseases
Progression of gait, speech and swallowing deficits in progressive supranuclear palsy.
Nervous System Diseases
Progressive supranuclear palsy combined with Alzheimer's disease: A clinicopathological study of two autopsy cases.
Nervous System Diseases
Progressive supranuclear palsy in a sample of Brazilian population: clinical features of 16 patients.
Nervous System Diseases
Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome.
Nervous System Diseases
Smad ubiquitination regulatory factor-2 in progressive supranuclear palsy.
Nervous System Diseases
Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy.
Nervous System Diseases
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.
Nervous System Diseases
Understanding the relationship between freezing of gait and other progressive supranuclear palsy features.
Neurobehavioral Manifestations
Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA.
Neurobehavioral Manifestations
Burden on caregivers of schizophrenia outpatients in Brazil: Relationship to symptomatology and functioning.
Neurobehavioral Manifestations
Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography.
Neurobehavioral Manifestations
Cognitive-behavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia.
Neurobehavioral Manifestations
Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis.
Neuroblastoma
An improved sensitive assay for the detection of PSP toxins with neuroblastoma cell-based impedance biosensor.
Neuroblastoma
Application of the neuroblastoma assay for paralytic shellfish poisons to neurotoxic freshwater cyanobacteria: interlaboratory calibration and comparison with other methods of analysis.
Neuroblastoma
Characterization of human and rat immortalized clones parotid acinar cells with respect to specific proteins and their mRNAs, and receptor-linked adenylate cyclase.
Neuroblastoma
Differential effects of physostigmine and organophosphates on nicotinic receptors in neuronal cells of different species.
Neuroblastoma
Effects of organophosphorus compounds on ATP production and mitochondrial integrity in cultured cells.
Neuroblastoma
Protective effect of polysaccharide peptide on cerebral ischemia?reperfusion injury in rats.
Neurodegenerative Diseases
A?1-15/16 as a potential diagnostic marker in neurodegenerative diseases.
Neurodegenerative Diseases
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.
Neurodegenerative Diseases
Alpha-synuclein Levels in the Differential Diagnosis of Lewy Bodies Dementia and Other Neurodegenerative Disorders: A Meta-analysis.
Neurodegenerative Diseases
An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy.
Neurodegenerative Diseases
Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy.
Neurodegenerative Diseases
Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.
Neurodegenerative Diseases
Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.
Neurodegenerative Diseases
Atrophy of superior cerebellar peduncle in progressive supranuclear palsy.
Neurodegenerative Diseases
Brain aconitase activity is not decreased in progressive supranuclear palsy.
Neurodegenerative Diseases
Cerebral oxygen metabolism in patients with progressive supranuclear palsy: a positron emission tomography study.
Neurodegenerative Diseases
Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
Neurodegenerative Diseases
Clinical features in association with neurodegenerative diseases and malignancies.
Neurodegenerative Diseases
Clusterin CSF levels in differential diagnosis of neurodegenerative disorders.
Neurodegenerative Diseases
Comprehensive mRNA expression profiling distinguishes tauopathies and identifies shared molecular pathways.
Neurodegenerative Diseases
Current and future treatments in progressive supranuclear palsy.
Neurodegenerative Diseases
Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies.
Neurodegenerative Diseases
Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases.
Neurodegenerative Diseases
Familial progressive supranuclear palsy. Description of a pedigree and review of the literature.
Neurodegenerative Diseases
Freezing of gait is an early clinical feature of progressive supranuclear palsy.
Neurodegenerative Diseases
High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy.
Neurodegenerative Diseases
In vivo binding of a tau imaging probe, [11 C]PBB3, in patients with progressive supranuclear palsy.
Neurodegenerative Diseases
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.
Neurodegenerative Diseases
Lack of association between progressive supranuclear palsy and arterial hypertension: a clinicopathological study.
Neurodegenerative Diseases
Long lasting pure freezing of gait preceding progressive supranuclear palsy: A clinicopathological study.
Neurodegenerative Diseases
Medical decision-making in progressive supranuclear palsy: A comparison to other neurodegenerative disorders.
Neurodegenerative Diseases
Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
Neurodegenerative Diseases
Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome.
Neurodegenerative Diseases
Myocardial (123)I-MIBG scintigraphy in patients with PSP, CBD and MSA.
Neurodegenerative Diseases
Neuromelanin-sensitive magnetic resonance imaging in disease differentiation for parkinsonism or neurodegenerative disease affecting the basal ganglia.
Neurodegenerative Diseases
Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.
Neurodegenerative Diseases
Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy.
Neurodegenerative Diseases
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy.
Neurodegenerative Diseases
Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders.
Neurodegenerative Diseases
Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study.
Neurodegenerative Diseases
Progressive Supranuclear Palsy - A Case Study from the Perspective of a Primary Care Physician Son.
Neurodegenerative Diseases
Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like magnetic resonance imaging features.
Neurodegenerative Diseases
Progressive Supranuclear Palsy with Wall-Eyed Bilateral Internuclear Ophthalmoplegia Syndrome: Authors' Second Case.
Neurodegenerative Diseases
Progressive supranuclear palsy: a review of co-existing neurodegeneration.
Neurodegenerative Diseases
Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors.
Neurodegenerative Diseases
Progressive supranuclear palsy: neuropathologic and clinical heterogeneity.
Neurodegenerative Diseases
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy.
Neurodegenerative Diseases
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy.
Neurodegenerative Diseases
STX6 rs1411478 is not associated with increased risk of Parkinson's disease.
Neurodegenerative Diseases
Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes.
Neurodegenerative Diseases
Tau imaging with [(18) F]THK-5351 in progressive supranuclear palsy.
Neurodegenerative Diseases
Tau Pathology Drives Dementia Risk-Associated Gene Networks toward Chronic Inflammatory States and Immunosuppression.
Neurodegenerative Diseases
To be or not to be: PP2A as a dual player in CNS functions, its role in neurodegeneration, and its interaction with brain insulin signaling.
Neurodegenerative Diseases
Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy.
Neurodegenerative Diseases
[11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy.
Neurodegenerative Diseases
[A case of progressive supranuclear palsy associated with bilateral vocal cord abductor paralysis]
Neurodegenerative Diseases
[Advance of SPECT: differential diagnosis and evaluation of pathophysiology of neurodegenerative disorders]
Neurodegenerative Diseases
[The application of Gallyas-Braak stainings in pathologic diagnosis of neurodegenerative diseases]
Neuroinflammatory Diseases
Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD.
Neuroinflammatory Diseases
Cytokine expression and microglial activation in progressive supranuclear palsy.
Neuroinflammatory Diseases
Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP).
Neuroinflammatory Diseases
Neuroinflammation and tau co-localize in vivo in progressive supranuclear palsy.
Neuroinflammatory Diseases
Neuroinflammation predicts disease progression in progressive supranuclear palsy.
Neuroinflammatory Diseases
Neutrophil-to-lymphocyte ratio (NLR) at boundaries of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS).
Neuroinflammatory Diseases
[11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy.
Nutrition Disorders
Radiolucent and calcified pancreatic lithiasis: two different diseases. Role of alcohol and heredity.
Obesity
Psycho-Physiological Responses to a 4-Month High-Intensity Interval Training-Centered Multidisciplinary Weight-Loss Intervention in Adolescents with Obesity.
Olfaction Disorders
A Card-type Odor Identification Test for Japanese Patients with Parkinson's Disease and Related Disorders.
Oligodendroglioma
Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma.
Oligodendroglioma
Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas.
Olivopontocerebellar Atrophies
Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy.
Olivopontocerebellar Atrophies
[Vertical oculomotor disorders in progressive supranuclear palsy and spino-cerebellar degeneration]
Ophthalmoplegia
Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy.
Ophthalmoplegia
Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy.
Ophthalmoplegia
Exodeviated ophthalmoplegia in a patient with progressive supranuclear palsy.
Ophthalmoplegia
Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Ophthalmoplegia
Long-term follow-up of deep brain stimulation of peduncolopontine nucleus in progressive supranuclear palsy: Report of three cases.
Ophthalmoplegia
Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques.
Ophthalmoplegia
Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases.
Ophthalmoplegia
[Cerebral blood flow and oxygen metabolism in patients with pure akinesia and progressive supranuclear palsy]
Ophthalmoplegia
[Improvement of ophthalmoplegia by 5-hydroxytryptophan in two cases of progressive supranuclear palsy]
Ophthalmoplegia
[Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of a case and review of the literature]
Ophthalmoplegia
[Widespread argentophilic structures in progressive supranuclear palsy--an autopsy case report]
Osteoarthritis
Effect of non-steroidal anti-inflammatory drugs on osteoarthritis of the knee. With special reference to PSP clearance as an indicator.
Osteoarthritis
Effect of Non-Steroidal Anti-Inflammatory Drugs on Osteoarthritis of the Knee: With Special Reference to PSP Clearance as an Indicator.
Osteoarthritis
[Effect of non-steroid anti-inflammatory drugs for osteoarthritis of the knee; PSP clearance test]
Osteoarthritis, Knee
Effect of non-steroidal anti-inflammatory drugs on osteoarthritis of the knee. With special reference to PSP clearance as an indicator.
Osteoarthritis, Knee
Effect of Non-Steroidal Anti-Inflammatory Drugs on Osteoarthritis of the Knee: With Special Reference to PSP Clearance as an Indicator.
Osteoarthritis, Knee
[Effect of non-steroid anti-inflammatory drugs for osteoarthritis of the knee; PSP clearance test]
Osteolysis
Polygonatum sibiricum polysaccharide inhibits osteoporosis by promoting osteoblast formation and blocking osteoclastogenesis through Wnt/?-catenin signalling pathway.
Osteomyelitis
Procalcitonin and Pancreatic Stone Protein Function as Biomarkers in Early Diagnosis of Pediatric Acute Osteomyelitis.
Osteoporosis
Abnormal bone mineral density and bone turnover marker expression profiles in patients with primary spontaneous pneumothorax.
Osteoporosis
Effects of Polygonatum sibiricum polysaccharide on the osteogenic differentiation of bone mesenchymal stem cells in mice.
Osteoporosis
Polygonatum sibiricum polysaccharide inhibits osteoporosis by promoting osteoblast formation and blocking osteoclastogenesis through Wnt/?-catenin signalling pathway.
Osteoporosis
Polygonatum Sibiricum Polysaccharide Promotes Osteoblastic Differentiation Through the ERK/GSK-3?/?-Catenin Signaling Pathway In Vitro.
Osteoporosis
The Role and Mechanism of miRNA-1224 in the Polygonatum Sibiricum Polysaccharide Regulation of Bone Marrow-Derived Macrophages to Osteoclast Differentiation.
Ovarian Neoplasms
Independent action of serine/threonine protein phosphatase in ovarian cancer plasma membrane and cytosol during gonadotropin-releasing hormone stimulation.
Pancreaticobiliary Maljunction
Activated pancreatic enzyme and pancreatic stone protein (PSP/reg) in bile of patients with pancreaticobiliary maljunction/ choledochal cysts.
Pancreatitis
Change of pancreatic enzymes, pancreatic stone protein (PSP), and plasma alpha(2)-macroglobulin-trypsin complex-like substance (MTLS) in the activation of pancreatic juice.
Pancreatitis
Chronic calcifying pancreatitis: epidemiology and current concept of the lithogenesis.
Pancreatitis
Exocrine meets endocrine: pancreatic stone protein and regenerating protein--two sides of the same coin.
Pancreatitis
Pancreatic Stent or Rectal Indomethacin-Which Better Prevents Post-ERCP Pancreatitis?: A Propensity Score Matching Analysis.
Pancreatitis
Pancreatic stone protein: quantification in pancreatic juice by enzyme-linked immunosorbent assay and comparison with other methods.
Pancreatitis
Prophylactic effect of rectal indomethacin plus nitroglycerin administration for preventing pancreatitis after endoscopic retrograde cholangiopancreatography in female patients.
Pancreatitis
Role of Pancreatic Stone Protein as an Early Biomarker for Risk Stratification of Acute Pancreatitis.
Pancreatitis
Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis.
Pancreatitis, Chronic
Idiopathic chronic calcifying pancreatitis with diabetes mellitus. Analysis of pancreatic stone protein gene.
Pancreatitis, Chronic
Immunocytochemical localization of pancreatic stone protein in the human digestive tract.
Pancreatitis, Chronic
Organic matrix of pancreatic stones associated with nutritional pancreatitis.
Pancreatitis, Chronic
Pancreatic stone protein and lactoferrin in human pancreatic juice in chronic pancreatitis.
Pancreatitis, Chronic
[Clinical trial on pancreatic duct stones caused by chronic pancreatitis.]
Paralysis
A new noninvasive test to detect mitochondrial dysfunction of skeletal muscles in progressive supranuclear palsy.
Paralysis
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Paralysis
Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and Neuroprotection and Natural History in Parkinson Plus Syndromes Criteria for the Diagnosis of Progressive Supranuclear Palsy.
Paralysis
Alterations of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic produced in rat brain tissues after systemic administration of saxitoxin.
Paralysis
An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability.
Paralysis
Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
Paralysis
APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.
Paralysis
Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
Paralysis
Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging.
Paralysis
Association of an extended haplotype in the tau gene with progressive supranuclear palsy.
Paralysis
Association of Tripartite Motif Containing 11 rs564309 with Tau Pathology in Progressive Supranuclear Palsy.
Paralysis
Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes.
Paralysis
Balance and eye movement training to improve gait in people with progressive supranuclear palsy: quasi-randomized clinical trial.
Paralysis
Behavioral changes as the earliest clinical manifestation of progressive supranuclear palsy.
Paralysis
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Paralysis
Blood-Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic Encephalopathy.
Paralysis
Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing.
Paralysis
Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy.
Paralysis
Cerebral oxygen metabolism in patients with progressive supranuclear palsy: a positron emission tomography study.
Paralysis
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
Paralysis
Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study.
Paralysis
Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy.
Paralysis
Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study.
Paralysis
Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration.
Paralysis
Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology.
Paralysis
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
Paralysis
Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy.
Paralysis
Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
Paralysis
Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center.
Paralysis
Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease.
Paralysis
Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy.
Paralysis
Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy.
Paralysis
Cortical Alzheimer Type Pathology Does Not Influence tau Pathology in Progressive Supranuclear Palsy.
Paralysis
Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
Paralysis
Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype.
Paralysis
CSF sAPP? and sAPP? levels in Alzheimer's Disease and Multiple Other Neurodegenerative Diseases: A Network Meta-Analysis.
Paralysis
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.
Paralysis
Deficits in long-term retention of learned motor skills in patients with cortical or subcortical degeneration.
Paralysis
Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study.
Paralysis
Difficulties in the diagnosis of four repeats (4R) tauopathic parkinsonian syndromes.
Paralysis
Distribution of tuft-shaped astrocytes in the cerebral cortex in progressive supranuclear palsy.
Paralysis
Electrophysiological features of lower motor neuron involvement in progressive supranuclear palsy.
Paralysis
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
Paralysis
Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.
Paralysis
Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy.
Paralysis
Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases.
Paralysis
Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
Paralysis
FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations.
Paralysis
Functional correlates of vertical gaze palsy and other ocular motor deficits in PSP: an FDG-PET study.
Paralysis
Further extension of the H1 haplotype associated with progressive supranuclear palsy.
Paralysis
Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Paralysis
Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels.
Paralysis
Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study.
Paralysis
Improvement of gaze control after balance and eye movement training in patients with progressive supranuclear palsy: a quasi-randomized controlled trial.
Paralysis
Influence of target size on vertical gaze palsy in a pathologically proven case of progressive supranuclear palsy.
Paralysis
Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology.
Paralysis
Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study.
Paralysis
Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy.
Paralysis
Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.
Paralysis
Microtubule-associated protein tau genetic variations are uncommon cause of frontotemporal dementia in south India.
Paralysis
MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy.
Paralysis
MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease.
Paralysis
MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome.
Paralysis
Natural clinical course of progressive supranuclear palsy in Chinese patients in Hong Kong.
Paralysis
Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
Paralysis
Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau.
Paralysis
Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Paralysis
Obsessive compulsive personality disorder in Progressive Supranuclear Palsy, Multiple System Atrophy and Essential Tremor.
Paralysis
Parkinson disease and progressive supranuclear palsy: protein expression in skin.
Paralysis
Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses.
Paralysis
Parkinsonism with newly diagnosed flare-up rheumatoid arthritis mimicking progressive supranuclear palsy.
Paralysis
Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Paralysis
Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann-Pick disease type C.
Paralysis
Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Paralysis
Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group.
Paralysis
Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study.
Paralysis
Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study.
Paralysis
Progression of gait, speech and swallowing deficits in progressive supranuclear palsy.
Paralysis
Progression of white matter damage in progressive supranuclear palsy with predominant parkinsonism.
Paralysis
Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology.
Paralysis
Progressive Supranuclear Gaze Palsy with Predominant Cerebellar Ataxia: A Case Series with Videos.
Paralysis
Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.
Paralysis
Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Paralysis
Progressive supranuclear palsy responding to intravenous thiamine: superimposed Wernicke's encephalopathy?
Paralysis
Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis.
Paralysis
Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome.
Paralysis
Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism?
Paralysis
Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
Paralysis
Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy.
Paralysis
Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of parkinsonism-dementia complex of Guam but not alzheimer's disease or progressive supranuclear palsy.
Paralysis
Research goals in progressive supranuclear palsy. First International Brainstorming Conference on PSP.
Paralysis
Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetry.
Paralysis
Reversible progressive supranuclear palsy-like phenotype as an initial manifestation of HIV infection.
Paralysis
Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
Paralysis
Selective decrease of large neurons in the neostriatum in progressive supranuclear palsy.
Paralysis
Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
Paralysis
Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms.
Paralysis
Sleep disturbances in the speech-language variant of progressive supranuclear palsy.
Paralysis
Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Paralysis
Spinocerebellar degeneration: Discrepancies between clinical and pathological diagnoses.
Paralysis
Structural and functional meta-analytic evidence for fronto-subcortical system deficit in progressive supranuclear palsy.
Paralysis
Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.
Paralysis
Superficial or partial superficial parotidectomy for the treatment of primary benign parotid tumors.
Paralysis
The auditory startle response in parkinsonism may reveal the extent but not type of pathology.
Paralysis
The Cure PSP Care Guide: A Telephonic Nursing Intervention for Individuals and Families Living With Progressive Supranuclear Palsy.
Paralysis
The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy.
Paralysis
The diagnosis of neurodegenerative disorders based on clinical and pathological findings using an MRI approach.
Paralysis
The diagnosis of progressive supranuclear palsy: current opinions and challenges.
Paralysis
The ratio of square wave jerk rates to blink rates distinguishes progressive supranuclear palsy from Parkinson disease.
Paralysis
The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome-A Pilot Study.
Paralysis
The syndrome of 'pure akinesia' and its relationship to progressive supranuclear palsy.
Paralysis
Transcranial brain sonography findings in two main variants of progressive supranuclear palsy.
Paralysis
Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
Paralysis
Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy.
Paralysis
What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features?
Paralysis
Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Paralysis
[A case of a syndrome resembling PSP after aortic arch replacement under deep hypothermic circulatory arrest].
Paralysis
[A clinical case of progressive supranuclear palsy with long-term frontal presentation preceding the onset of gaze palsy].
Paralysis
[Adult-onset dementia with abundant neurofibrillary tangles resembling progressive supranuclear palsy]
Paralysis
[An autopsy case of corticobasal degeneration without prominent cortical pathology--an imitator of progressive supranuclear palsy]
Paralysis
[Cerebral blood flow and oxygen metabolism in patients with pure akinesia and progressive supranuclear palsy]
Paralysis
[Clinical analysis of paralytic shellfish poisoning following ingestion of oysters]
Paralysis
[Contribution of oculomotor examination for the etiological diagnosis of parkinsonian syndromes]
Paralysis
[Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis]
Paralysis
[Partial superficial parotidectomy versus superficial parotidectomy for treatment of parotid benign tumors: evidence-based medicine analysis].
Paralysis
[Progressive supranuclear paralysis. Quantification of dopamine D2 receptors using radionuclide tomography]
Paralysis
[Successful outcome of VP shunt operation in 3 cases of idiopathic normal pressure hydrocephalus with long duration of illness]
Paralysis
[Vertical oculomotor disorders in progressive supranuclear palsy and spino-cerebellar degeneration]
Paresis
[Partial superficial parotidectomy versus superficial parotidectomy for treatment of parotid benign tumors: evidence-based medicine analysis].
Paresthesia
Case diagnosis and characterization of suspected paralytic shellfish poisoning in Alaska.
Paresthesia
Comparison of single-port vs. two-port VATS technique for primary spontaneous pneumothorax.
Paresthesia
Early outcomes of single-port video-assisted thoracic surgery for primary spontaneous pneumothorax.
Paresthesia
Incidence of chest wall paresthesia after video-assisted thoracic surgery for primary spontaneous pneumothorax.
Paresthesia
Thalamic stimulation-evoked sensations in chronic pain patients and in nonpain (movement disorder) patients.
Paresthesia
Uniportal vs. triportal video-assisted thoracic surgery in the treatment of primary pneumothorax-a propensity matched bicentric study.
Parkinson Disease
123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study.
Parkinson Disease
A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
Parkinson Disease
A Cortical Substrate for Square-Wave Jerks in Progressive Supranuclear Palsy.
Parkinson Disease
A novel diagnostic marker for progressive supranuclear palsy targeting atrophy of the subthalamic nucleus.
Parkinson Disease
A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism.
Parkinson Disease
Abnormal signals on proton density-weighted MRI of the superior cerebellar peduncle in progressive supranuclear palsy.
Parkinson Disease
Abnormalities of optokinetic nystagmus in progressive supranuclear palsy.
Parkinson Disease
Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
Parkinson Disease
Alterations of neurotransmitter receptors and neurotransmitter transporters in progressive supranuclear palsy.
Parkinson Disease
Amantadine-induced myoclonus in a patient with progressive supranuclear palsy.
Parkinson Disease
An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease.
Parkinson Disease
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
Parkinson Disease
Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
Parkinson Disease
Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy.
Parkinson Disease
Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis.
Parkinson Disease
Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy.
Parkinson Disease
Benzodiazepine receptors in normal human brain, in Parkinson's disease and in progressive supranuclear palsy.
Parkinson Disease
Brain somatostatin concentrations do not decrease in progressive supranuclear palsy.
Parkinson Disease
Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing.
Parkinson Disease
Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP).
Parkinson Disease
Cerebellar dysfunction in progressive supranuclear palsy: a transcranial magnetic stimulation study.
Parkinson Disease
Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study.
Parkinson Disease
Clinical analysis of blepharospasm and apraxia of eyelid opening in patients with parkinsonism.
Parkinson Disease
Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
Parkinson Disease
Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Parkinson Disease
Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology.
Parkinson Disease
Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy.
Parkinson Disease
Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy.
Parkinson Disease
Cognition in corticobasal syndrome and progressive supranuclear palsy: a review.
Parkinson Disease
Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes.
Parkinson Disease
Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
Parkinson Disease
Comparison of REM sleep behaviour disorder variables between patients with progressive supranuclear palsy and those with Parkinson's disease.
Parkinson Disease
Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy.
Parkinson Disease
Corneal Sensitivity, Blink Rate, and Corneal Nerve Density in Progressive Supranuclear Palsy and Parkinson Disease.
Parkinson Disease
Correlation between qualitative balance indices, dynamic posturography and structural brain imaging in patients with progressive supranuclear palsy and its subtypes.
Parkinson Disease
CSF sAPP? and sAPP? levels in Alzheimer's Disease and Multiple Other Neurodegenerative Diseases: A Network Meta-Analysis.
Parkinson Disease
Cutaneous sensory and autonomic denervation in progressive supranuclear palsy.
Parkinson Disease
D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
Parkinson Disease
Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.
Parkinson Disease
Deficits in long-term retention of learned motor skills in patients with cortical or subcortical degeneration.
Parkinson Disease
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
Parkinson Disease
Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study.
Parkinson Disease
Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism.
Parkinson Disease
Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease.
Parkinson Disease
Differentiating PSP from MSA using MR planimetric measurements: a systematic review and meta-analysis.
Parkinson Disease
Differentiation of Parkinson's disease and progressive supranuclear palsy with magnetic resonance imaging: The first Brazilian experience.
Parkinson Disease
Diffusion tensor analysis of corpus callosum in progressive supranuclear palsy.
Parkinson Disease
Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Parkinson Disease
Disease course and treatment patterns in progressive supranuclear palsy: A real-world study.
Parkinson Disease
Effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review.
Parkinson Disease
Effects of Lee Silverman Voice Treatment (LSVT LOUD) on Swallowing in Patients with Progressive Supranuclear Palsy: A Pilot Study.
Parkinson Disease
Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy.
Parkinson Disease
Enlargements of somatosensory-evoked potentials in progressive supranuclear palsy.
Parkinson Disease
Essential tremor followed by progressive supranuclear palsy: postmortem reports of 11 patients.
Parkinson Disease
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
Parkinson Disease
Executive dysfunction, behavioral changes and quality of life in Chinese patients with progressive supranuclear palsy.
Parkinson Disease
Eye movement deficits in X-linked dystonia-parkinsonism are related to striatal degeneration.
Parkinson Disease
Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy.
Parkinson Disease
Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy.
Parkinson Disease
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study.
Parkinson Disease
Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Parkinson Disease
Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017.
Parkinson Disease
Immediate Effects of Sensorimotor Training in Airway Protection (smTAP) on Cough Outcomes in Progressive Supranuclear Palsy: A Feasibility Study.
Parkinson Disease
Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism.
Parkinson Disease
Iron accumulation in the oculomotor nerve of the progressive supranuclear palsy brain.
Parkinson Disease
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.
Parkinson Disease
Lewy bodies in progressive supranuclear palsy represent an independent disease process.
Parkinson Disease
Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study.
Parkinson Disease
Limited usefulness of electroconvulsive therapy in progressive supranuclear palsy.
Parkinson Disease
Local cerebral blood flow and its response to intravenous levodopa in progressive supranuclear palsy. Comparison with Parkinson's disease.
Parkinson Disease
Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.
Parkinson Disease
Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.
Parkinson Disease
Midbrain hypometabolism as early diagnostic sign for progressive supranuclear palsy.
Parkinson Disease
Morning glory sign: a particular MR finding in progressive supranuclear palsy.
Parkinson Disease
MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease.
Parkinson Disease
Muscarinic receptors in the thalamus in progressive supranuclear palsy and other neurodegenerative disorders.
Parkinson Disease
Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
Parkinson Disease
Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
Parkinson Disease
Neuronal loss in the basal nucleus of Meynert in progressive supranuclear palsy.
Parkinson Disease
Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy.
Parkinson Disease
Non motor symptoms in progressive supranuclear palsy: prevalence and severity.
Parkinson Disease
Parkinson disease and progressive supranuclear palsy: protein expression in skin.
Parkinson Disease
Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses.
Parkinson Disease
Parkinsonism and dystonia caused by the illicit use of ephedrone--a longitudinal study.
Parkinson Disease
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
Parkinson Disease
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy.
Parkinson Disease
Patterns of abnormal motor cortex excitability in atypical parkinsonian syndromes.
Parkinson Disease
Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Parkinson Disease
Pedunculopontine tegmentum cholinergic loss leads to a progressive decline in motor abilities and neuropathological changes resembling progressive supranuclear palsy.
Parkinson Disease
Persephin-overexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinson's disease.
Parkinson Disease
Phonemic fluency quantity and quality: Comparing patients with PSP, Parkinson's disease and focal frontal and subcortical lesions.
Parkinson Disease
Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Parkinson Disease
Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group.
Parkinson Disease
Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study.
Parkinson Disease
Prediction of the Clinical Severity of Progressive Supranuclear Palsy by Diffusion Tensor Imaging.
Parkinson Disease
Preferential neurodegeneration in the cervical spinal cord of progressive supranuclear palsy.
Parkinson Disease
Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene.
Parkinson Disease
Progressive supranuclear palsy misdiagnosed as Parkinson's disease: a case report and review of literature.
Parkinson Disease
Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like magnetic resonance imaging features.
Parkinson Disease
Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P)-A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD).
Parkinson Disease
Progressive supranuclear palsy: neuropathologic and clinical heterogeneity.
Parkinson Disease
Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy.
Parkinson Disease
Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
Parkinson Disease
Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy.
Parkinson Disease
Regional brain atrophy in progressive supranuclear palsy and Lewy body disease.
Parkinson Disease
Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
Parkinson Disease
Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments.
Parkinson Disease
Role of Corpus Callosum Volumetry in Differentiating the Subtypes of Progressive Supranuclear Palsy and Early Parkinson's Disease.
Parkinson Disease
Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
Parkinson Disease
Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease.
Parkinson Disease
Sensorimotor Cough Dysfunction Is Prevalent and Pervasive in Progressive Supranuclear Palsy.
Parkinson Disease
Serum adiponectin levels between patients with Parkinson's disease and those with PSP.
Parkinson Disease
Spatial attention and spatial short term memory in PSP and Parkinson's disease.
Parkinson Disease
Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Parkinson Disease
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy.
Parkinson Disease
STX6 rs1411478 is not associated with increased risk of Parkinson's disease.
Parkinson Disease
Subregional Pattern of Striatal Dopamine Transporter Loss on 18F FP-CIT Positron Emission Tomography in Patients With Pure Akinesia With Gait Freezing.
Parkinson Disease
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
Parkinson Disease
The auditory startle response in parkinsonism may reveal the extent but not type of pathology.
Parkinson Disease
The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy.
Parkinson Disease
The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
Parkinson Disease
The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease.
Parkinson Disease
The ratio of square wave jerk rates to blink rates distinguishes progressive supranuclear palsy from Parkinson disease.
Parkinson Disease
The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease.
Parkinson Disease
Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
Parkinson Disease
Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
Parkinson Disease
Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes.
Parkinson Disease
Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology.
Parkinson Disease
Understanding the relationship between freezing of gait and other progressive supranuclear palsy features.
Parkinson Disease
Utility and accuracy of perceptual voice and speech distinctions in the diagnosis of Parkinson's disease, PSP and MSA-P.
Parkinson Disease
Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease.
Parkinson Disease
Validation of the Parkinson's Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy.
Parkinson Disease
Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy.
Parkinson Disease
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
Parkinson Disease
Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Parkinson Disease
Whole-Brain Atrophy Differences between Progressive Supranuclear Palsy and Idiopathic Parkinson's Disease.
Parkinson Disease
Whole-Brain Atrophy Rate in Idiopathic Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.
Parkinson Disease
[Autonomic nervous function in progressive supranuclear palsy--comparison with Parkinson's disease and healthy controls]
Parkinson Disease
[Progressive supranuclear palsy : Living environment of the patients in Germany.]
Parkinson Disease
[Progressive supranuclear paralysis. Quantification of dopamine D2 receptors using radionuclide tomography]
Parkinson Disease
[Semiquantitative evaluation of cranial computerized tomography as diagnostic support in progressive supranuclear palsy]
Parkinson Disease, Postencephalitic
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Parkinson Disease, Postencephalitic
Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings.
Parkinson Disease, Postencephalitic
Progressive supranuclear palsy: clinico-pathological and biochemical studies.
Parkinson Disease, Postencephalitic
Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism?
Parkinson Disease, Postencephalitic
Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.
Parkinson Disease, Postencephalitic
What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features?
Parkinsonian Disorders
'Hummingbird' Sign in a Patient with Guam Parkinsonism-Dementia Complex.
Parkinsonian Disorders
A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
Parkinsonian Disorders
A new noninvasive test to detect mitochondrial dysfunction of skeletal muscles in progressive supranuclear palsy.
Parkinsonian Disorders
A novel diagnostic marker for progressive supranuclear palsy targeting atrophy of the subthalamic nucleus.
Parkinsonian Disorders
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders.
Parkinsonian Disorders
Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and Neuroprotection and Natural History in Parkinson Plus Syndromes Criteria for the Diagnosis of Progressive Supranuclear Palsy.
Parkinsonian Disorders
Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
Parkinsonian Disorders
An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant.
Parkinsonian Disorders
Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia.
Parkinsonian Disorders
Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis.
Parkinsonian Disorders
Atypical parkinsonian syndromes in a North African tertiary referral center.
Parkinsonian Disorders
Atypical parkinsonism on Guadeloupe, comparison with the parkinsonism-dementia complex of Guam, and environmental toxic hypotheses.
Parkinsonian Disorders
Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes.
Parkinsonian Disorders
Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study.
Parkinsonian Disorders
Automated MRI Classification in Progressive Supranuclear Palsy: a Large International Cohort Study.
Parkinsonian Disorders
Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia.
Parkinsonian Disorders
Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.
Parkinsonian Disorders
C9orf72 and its Relevance in Parkinsonism and Movement Disorders: A Comprehensive Review of the Literature.
Parkinsonian Disorders
Central auditory processing in parkinsonian disorders: A systematic review.
Parkinsonian Disorders
Cerebral peduncle angle: Unreliable in differentiating progressive supranuclear palsy from other neurodegenerative diseases.
Parkinsonian Disorders
Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome.
Parkinsonian Disorders
Clinical analysis of blepharospasm and apraxia of eyelid opening in patients with parkinsonism.
Parkinsonian Disorders
Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration.
Parkinsonian Disorders
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy.
Parkinsonian Disorders
Clinical Utility of 18 F-APN-1607 Tau PET Imaging in Patients with Progressive Supranuclear Palsy.
Parkinsonian Disorders
Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report.
Parkinsonian Disorders
Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
Parkinsonian Disorders
Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
Parkinsonian Disorders
Combined measurement of plasma cystatin C and low-density lipoprotein cholesterol: A valuable tool for evaluating progressive supranuclear palsy.
Parkinsonian Disorders
Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center.
Parkinsonian Disorders
Comparison of REM sleep behaviour disorder variables between patients with progressive supranuclear palsy and those with Parkinson's disease.
Parkinsonian Disorders
Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
Parkinsonian Disorders
Deep learning to differentiate parkinsonian disorders separately using single midsagittal MR imaging: a proof of concept study.
Parkinsonian Disorders
Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study.
Parkinsonian Disorders
Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
Parkinsonian Disorders
Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism.
Parkinsonian Disorders
Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.
Parkinsonian Disorders
Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism.
Parkinsonian Disorders
Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders.
Parkinsonian Disorders
Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Parkinsonian Disorders
Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography.
Parkinsonian Disorders
Differentiating PSP from MSA using MR planimetric measurements: a systematic review and meta-analysis.
Parkinsonian Disorders
Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging.
Parkinsonian Disorders
Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats.
Parkinsonian Disorders
Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism.
Parkinsonian Disorders
Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes.
Parkinsonian Disorders
Early Impairment of Chopsticks Skills in Parkinsonism Suggests Progressive Supranuclear Palsy.
Parkinsonian Disorders
Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy.
Parkinsonian Disorders
Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.
Parkinsonian Disorders
Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy.
Parkinsonian Disorders
Familial aggregation in atypical Parkinson's disease: a case control study in multiple system atrophy and progressive supranuclear palsy.
Parkinsonian Disorders
Familial aggregation in Progressive Supranuclear Palsy and Corticobasal Syndrome.
Parkinsonian Disorders
Familial aggregation of parkinsonism in progressive supranuclear palsy.
Parkinsonian Disorders
Freezing of gait is an early clinical feature of progressive supranuclear palsy.
Parkinsonian Disorders
FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations.
Parkinsonian Disorders
Functional MRI of disease progression in Parkinson disease and atypical parkinsonian syndromes.
Parkinsonian Disorders
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study.
Parkinsonian Disorders
Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Parkinsonian Disorders
Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017.
Parkinsonian Disorders
How do patients with parkinsonism present? A clinicopathological study.
Parkinsonian Disorders
How to spot ocular abnormalities in progressive supranuclear palsy? A practical review.
Parkinsonian Disorders
Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism.
Parkinsonian Disorders
Improved language production with transcranial direct current stimulation in progressive supranuclear palsy.
Parkinsonian Disorders
Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.
Parkinsonian Disorders
Increased Signal in the Superior Cerebellar Peduncle of Patients with Progressive Supranuclear Palsy.
Parkinsonian Disorders
Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology.
Parkinsonian Disorders
Late-onset Niemann-Pick disease type C overlapping with frontotemporal dementia syndromes: a case report.
Parkinsonian Disorders
Levodopa-induced facial dystonia in a case of progressive supranuclear palsy.
Parkinsonian Disorders
Long-term follow-up of deep brain stimulation of peduncolopontine nucleus in progressive supranuclear palsy: Report of three cases.
Parkinsonian Disorders
Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Parkinsonian Disorders
Magnetic resonance parkinsonism indices and interpeduncular angle in idiopathic normal pressure hydrocephalus and progressive supranuclear palsy.
Parkinsonian Disorders
Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism.
Parkinsonian Disorders
Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.
Parkinsonian Disorders
Midbrain MRI assessments in progressive supranuclear palsy subtypes.
Parkinsonian Disorders
Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
Parkinsonian Disorders
Morning glory sign: a particular MR finding in progressive supranuclear palsy.
Parkinsonian Disorders
Motor programming is more affected in progressive supranuclear palsy than in Parkinson's disease: a spatiotemporal study of event-related desynchronization.
Parkinsonian Disorders
MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism.
Parkinsonian Disorders
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
Parkinsonian Disorders
MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease.
Parkinsonian Disorders
MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism.
Parkinsonian Disorders
MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.
Parkinsonian Disorders
MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
Parkinsonian Disorders
MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice.
Parkinsonian Disorders
MRI measurements predict PSP in unclassifiable parkinsonisms: A cohort study.
Parkinsonian Disorders
Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome.
Parkinsonian Disorders
Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.
Parkinsonian Disorders
Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
Parkinsonian Disorders
Neuromelanin-sensitive magnetic resonance imaging in disease differentiation for parkinsonism or neurodegenerative disease affecting the basal ganglia.
Parkinsonian Disorders
Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Parkinsonian Disorders
Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP?
Parkinsonian Disorders
Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.
Parkinsonian Disorders
Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.
Parkinsonian Disorders
Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy.
Parkinsonian Disorders
Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings.
Parkinsonian Disorders
Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses.
Parkinsonian Disorders
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
Parkinsonian Disorders
Pathophysiology of slow vertical saccades in progressive supranuclear palsy.
Parkinsonian Disorders
Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group.
Parkinsonian Disorders
Preferential neurodegeneration in the cervical spinal cord of progressive supranuclear palsy.
Parkinsonian Disorders
Presynaptic striatal dopaminergic function in atypical parkinsonisms: A meta-analysis of imaging studies.
Parkinsonian Disorders
Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis.
Parkinsonian Disorders
Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD.
Parkinsonian Disorders
Progression of falls in postmortem-confirmed parkinsonian disorders.
Parkinsonian Disorders
Progression of white matter damage in progressive supranuclear palsy with predominant parkinsonism.
Parkinsonian Disorders
Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology.
Parkinsonian Disorders
Progressive spasticity, supranuclear gaze palsy and postural instability, without parkinsonism: what's in a phenotype?
Parkinsonian Disorders
Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Parkinsonian Disorders
Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options.
Parkinsonian Disorders
Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism.
Parkinsonian Disorders
Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy.
Parkinsonian Disorders
Progressive supranuclear palsy: a clinicopathological study of 21 cases.
Parkinsonian Disorders
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges.
Parkinsonian Disorders
Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
Parkinsonian Disorders
Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
Parkinsonian Disorders
Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study.
Parkinsonian Disorders
Role of Corpus Callosum Volumetry in Differentiating the Subtypes of Progressive Supranuclear Palsy and Early Parkinson's Disease.
Parkinsonian Disorders
Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
Parkinsonian Disorders
Sensorimotor Cough Dysfunction Is Prevalent and Pervasive in Progressive Supranuclear Palsy.
Parkinsonian Disorders
Signal changes of superior cerebellar peduncle on fluid-attenuated inversion recovery in progressive supranuclear palsy.
Parkinsonian Disorders
Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy.
Parkinsonian Disorders
Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy.
Parkinsonian Disorders
Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Parkinsonian Disorders
Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy.
Parkinsonian Disorders
Suicidal and death ideation in patients with progressive supranuclear palsy and corticobasal syndrome.
Parkinsonian Disorders
Swallow tail sign on susceptibility map-weighted imaging (SMWI) for disease diagnosing and severity evaluating in parkinsonism.
Parkinsonian Disorders
The contribution of trigemino-cervical reflexes in distinguishing progressive supranuclear palsy from multiple system atrophy.
Parkinsonian Disorders
The diagnosis of progressive supranuclear palsy: current opinions and challenges.
Parkinsonian Disorders
The effect of repeated administrations of granulocyte colony stimulating factor for blood stem cells mobilization in patients with progressive supranuclear palsy, corticobasal degeneration and multiple system atrophy.
Parkinsonian Disorders
The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.
Parkinsonian Disorders
The PSP-associated MAPT H1 subhaplotype in Guadeloupean atypical parkinsonism.
Parkinsonian Disorders
The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage.
Parkinsonian Disorders
The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome-A Pilot Study.
Parkinsonian Disorders
Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study.
Parkinsonian Disorders
Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
Parkinsonian Disorders
Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes.
Parkinsonian Disorders
Undetectable specific striatal [¹²³I]-ioflupane binding in patients with parkinsonism.
Parkinsonian Disorders
Untangling the tau gene association with neurodegenerative disorders.
Parkinsonian Disorders
Validation of the Italian version of carers' quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy.
Parkinsonian Disorders
Vertical wrinkling of the forehead or Procerus sign in Progressive Supranuclear Palsy.
Parkinsonian Disorders
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
Parkinsonian Disorders
Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Parkinsonian Disorders
[18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease]
Parkinsonian Disorders
[A 62-year-old Woman Presenting with Progressive Nonfluent Aphasia, Apraxia of Eyelid Opening, Supranuclear Gaze Palsy, and Asymmetric Rigidity].
Parkinsonian Disorders
[A 85-year-old woman with the onset of progressive gait disturbance at 80 years of the age]
Parkinsonian Disorders
[A case of progressive supranuclear palsy showing marked improvements of frontal hypoperfusion, as well as parkinsonism with amitriptyline]
Parkinsonian Disorders
[Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis]
Parkinsonian Disorders
[Dopamine agonists--clinical applications beyond Parkinson's disease]
Periodontal Diseases
Numerical Evaluation of Image Contrast for Thicker and Thinner Objects among Current Intraoral Digital Imaging Systems.
Periodontitis
Identification of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4-one derivatives as inhibitors of the phosphatase SerB653 in Porphyromonas gingivalis, implicated in periodontitis.
Peritonitis
Pancreatic stone protein (PSP) and pancreatitis-associated protein (PAP): a protocol of a cohort study on the diagnostic efficacy and prognostic value of PSP and PAP as postoperative markers of septic complications in patients undergoing abdominal surgery (PSP study).
Peritonitis
Pseudomonas peritonitis in peritoneal dialysis patients: the Network #9 Peritonitis Study.
Phantom Limb
Persistent socket pain postenucleation and post evisceration: a systematic review.
Pheochromocytoma
Germ cell mitogenic activity is associated with nerve growth factor-like protein(s).
Pheochromocytoma
Okadaic acid induces activator protein 1 activity and immediate early gene transcription in rat pheochromocytoma cells. Mechanism of action.
phosphoglycerate dehydrogenase deficiency
3-Phosphoglycerate dehydrogenase deficiency and 3-phosphoserine phosphatase deficiency: inborn errors of serine biosynthesis.
phosphoglycerate dehydrogenase deficiency
Continuing education in neurometabolic disorders--serine deficiency disorders.
phosphoglycerate dehydrogenase deficiency
Treatment with amino acids in serine deficiency disorders.
phosphoserine phosphatase deficiency
3-Phosphoglycerate dehydrogenase deficiency and 3-phosphoserine phosphatase deficiency: inborn errors of serine biosynthesis.
phosphoserine phosphatase deficiency
Continuing education in neurometabolic disorders--serine deficiency disorders.
phosphoserine phosphatase deficiency
Erratum to: Novel Report of Phosphoserine Phosphatase Deficiency in an Adult with Myeloneuropathy and Limb Contractures.
phosphoserine phosphatase deficiency
Mutations responsible for 3-phosphoserine phosphatase deficiency.
phosphoserine phosphatase deficiency
Novel Report of Phosphoserine Phosphatase Deficiency in an Adult with Myeloneuropathy and Limb Contractures.
phosphoserine phosphatase deficiency
Phosphoserine phosphatase deficiency in a patient with Williams syndrome.
phosphoserine phosphatase deficiency
Treatment with amino acids in serine deficiency disorders.
Photophobia
Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: A prospective study.
Pick Disease of the Brain
A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.
Pick Disease of the Brain
A Novel MAPT Mutation, G55R, in a Frontotemporal Dementia Patient Leads to Altered Tau Function.
Pick Disease of the Brain
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Pick Disease of the Brain
An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
Pick Disease of the Brain
Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
Pick Disease of the Brain
Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies.
Pick Disease of the Brain
Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.
Pick Disease of the Brain
Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats.
Pick Disease of the Brain
Distribution of cerebral cortical lesions in corticobasal degeneration: a clinicopathological study of five autopsy cases in Japan.
Pick Disease of the Brain
Frontotemporal lobar degeneration (FTLD) concept and classification update.
Pick Disease of the Brain
High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies.
Pick Disease of the Brain
Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.
Pick Disease of the Brain
New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies.
Pick Disease of the Brain
Pick Complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy.
Pick Disease of the Brain
Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies.
Pick Disease of the Brain
Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain.
Pick Disease of the Brain
Tau-positive fine granules in the cerebral white matter: a novel finding among the tauopathies exclusive to parkinsonism-dementia complex of Guam.
Pick Disease of the Brain
The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau.
Pick Disease of the Brain
Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies.
Pick Disease of the Brain
Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.
Pick Disease of the Brain
What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features?
Pick Disease of the Brain
Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Pick Disease of the Brain
[Frontotemporal lobar degeneration (FTLD) - changes of its concept and classification based on aggregated proteins].
Pleural Effusion
Digital chest radiography with storage phosphor systems: potential masking of bilateral pleural effusions.
Pneumonia
Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study.
Pneumonia
Natural clinical course of progressive supranuclear palsy in Chinese patients in Hong Kong.
Pneumonia
Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults: a case-control study.
Pneumonia
Post-stroke pneumonia at the stroke unit - a registry based analysis of contributing and protective factors.
Pneumonia
Repeated inhalation exposure of rats to an anionic high molecular weight polymer aerosol: Application of prediction models to better understand pulmonary effects and modes of action.
Pneumonia
Risk factors for and impact of poststroke pneumonia in patients with acute ischemic stroke.
Pneumonia
Sensorimotor Cough Dysfunction Is Prevalent and Pervasive in Progressive Supranuclear Palsy.
Pneumonia, Aspiration
A case of spinal anesthesia in a patient with progressive supranuclear palsy.
Pneumonia, Aspiration
Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study.
Pneumothorax
A Mysterious Case of Spontaneous Cervical Epidural Hematoma and Bilateral Primary Spontaneous Pneumothorax Caused by a Rare Etiology.
Pneumothorax
A Mysterious Case of Spontaneous Cervical Epidural Hematoma and Bilateral Primary Spontaneous Pneumothorax caused by a Rare Etiology.
Pneumothorax
A novel dual-covering method in video-assisted thoracic surgery for pediatric primary spontaneous pneumothorax.
Pneumothorax
A Prospective Randomized Trial Comparing Manual Needle Aspiration to Closed Thoracostomy as an Initial Treatment for the First Episode of Primary Spontaneous Pneumothorax.
Pneumothorax
Abnormal Changes of a 12-Lead Electrocardiogram in Male Patients with Left Primary Spontaneous Pneumothorax.
Pneumothorax
Additional mechanical pleurodesis after thoracoscopic wedge resection and covering procedure for primary spontaneous pneumothorax.
Pneumothorax
Alveolar epithelial permeability in patients with primary spontaneous pneumothorax as determined by Tc-99m DTPA aerosol scintigraphy.
Pneumothorax
Can CT scanning be used to select patients with unilateral primary spontaneous pneumothorax for bilateral surgery?
Pneumothorax
Cannabinoids Identification in Lung Tissues of Young Cannabis Smokers Operated for Primary Spontaneous Pneumothorax and Correlation with Pathologic Findings.
Pneumothorax
Characterisation of pleural inflammation occurring after primary spontaneous pneumothorax.
Pneumothorax
Clinical manifestations of primary spontaneous pneumothorax in pediatric patients: an analysis of 78 patients.
Pneumothorax
Clinical Profile of Spontaneous Pneumothorax in Adults: A Retrospective Study.
Pneumothorax
Comparison of single-port vs. two-port VATS technique for primary spontaneous pneumothorax.
Pneumothorax
Comparison of tracheal intubation with controlled ventilation and laryngeal mask airway with spontaneous ventilation for thoracoscopic bullectomy.
Pneumothorax
Correlation of Primary Spontaneous Pneumothorax and Air Pollution in Adolescents.
Pneumothorax
Data on the epidemiology, diagnosis, and treatment of patients with pneumothorax.
Pneumothorax
Do atmospheric conditions influence the first episode of primary spontaneous pneumothorax?
Pneumothorax
Expression of TGF-beta receptor 1 and Smads in the tissues of primary spontaneous pneumothorax.
Pneumothorax
Factors associated with proceeding to surgical intervention and recurrence of primary spontaneous pneumothorax in adolescent patients.
Pneumothorax
Fibulin-5 Protein Is Reduced in the Lung of Patients with Spontaneous Pneumothorax Who Are Under 25 Years Old.
Pneumothorax
Fibulin-5 protein is reduced in the lung of patients with spontaneous pneumothorax who are under 25 years old.
Pneumothorax
High-Resolution CT Following Primary Spontaneous Pneumothorax in Adolescents: Useful Tool or Wasted Radiation?
Pneumothorax
How should complete lung collapse secondary to primary spontaneous pneumothorax be managed??.
Pneumothorax
Identifying Primary Spontaneous Pneumothorax from Administrative Databases: A Validation Study.
Pneumothorax
Is it a myth to perform blind apical wedge resection in primary spontaneous pneumothorax surgery to improve recurrence rates?
Pneumothorax
Multicentric Genome-Wide Association Study for Primary Spontaneous Pneumothorax.
Pneumothorax
Mutation analysis of the FLCN gene in Chinese patients with sporadic and familial isolated primary spontaneous pneumothorax.
Pneumothorax
Natural Course of Spontaneous Pneumothorax without Bullae or Blebs under High-Resolution Computed Tomography.
Pneumothorax
Pleurectomy versus pleural abrasion for primary spontaneous pneumothorax in children.
Pneumothorax
Prediction of recurrent spontaneous pneumothorax: CT scan findings versus management features.
Pneumothorax
Primary and Secondary Spontaneous Pneumothorax: Prevalence, Clinical Features, and In-Hospital Mortality.
Pneumothorax
Primary Spontaneous Pneumothorax Admitted in Emergency Unit: Does First Episode Differ from Recurrence? A Cross-Sectional Study.
Pneumothorax
Recurrent primary spontaneous pneumothorax in a large Chinese family: a clinical and genetic investigation.
Pneumothorax
Role of Blebs and Bullae Detected by High-Resolution Computed Tomography and Recurrent Spontaneous Pneumothorax.
Pneumothorax
Size of Pneumothorax can be a New Indication for Surgical Treatment in Primary Spontaneous Pneumothorax: A Prospective Study.
Pneumothorax
Staple line coverage with absorbable mesh after thoracoscopic bullectomy for spontaneous pneumothorax.
Pneumothorax
The effect of pleural abrasion on the treatment of primary spontaneous pneumothorax: a systematic review of randomized controlled trials.
Pneumothorax
The influence of pleurodesis on the outcome of primary spontaneous pneumothorax in children.
Pneumothorax
The Size of Spontaneous Pneumothorax is a Predictor of Unsuccessful Catheter Drainage.
Pneumothorax
Video-assisted thoracoscopic surgery management of spontaneous pneumothorax - long-term results.
Pneumothorax
What is the difference in size of spontaneous pneumothorax between inspiratory and expiratory x-rays?
Pneumothorax
Will the presence of radiological signs of tension pneumothorax affect the clinical presentation of primary spontaneous pneumothorax?
Pneumothorax
[Video-assisted thoracic surgery in the treatment of spontaneous pneumothorax]
Polyneuropathies
High prevalence of false-negative anti-HTLV type I/II enzyme-linked immunosorbent assay results in HIV type 1-positive patients.
Polyneuropathies
Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study.
Polyradiculoneuropathy
[Clinical analysis of paralytic shellfish poisoning following ingestion of oysters]
Pressure Ulcer
Exploring the challenge of health research priority setting in partnership: reflections on the methodology used by the James Lind Alliance Pressure Ulcer Priority Setting Partnership.
Primary Dysautonomias
Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Primary Dysautonomias
Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy.
Primary Dysautonomias
Electrophysiological and clinical assessment of dysautonomia in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP): a comparative study.
Primary Dysautonomias
Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis.
Primary Progressive Nonfluent Aphasia
Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?
Primary Progressive Nonfluent Aphasia
Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology.
Prolactinoma
Pituitary tumors contain a side population with tumor stem cell-associated characteristics.
Prostatic Neoplasms
Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population.
Prostatic Neoplasms
Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma.
Prostatic Neoplasms
Polysaccharopeptide enhanced the anti-cancer effect of gamma-tocotrienol through activation of AMPK.
Prostatic Neoplasms
Procyanidin from peanut skin induces antiproliferative effect in human prostate carcinoma cells DU145.
Prostatic Neoplasms
Recent Advances and Challenges in Studies of Control of Cancer Stem Cells and the Gut Microbiome by the Trametes-Derived Polysaccharopeptide PSP (Review).
Prostatic Neoplasms
Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer.
Prostatic Neoplasms
Two-site monoclonal antibody-based immunoradiometric assay for measuring prostate secretory protein in serum.
Prostatic Neoplasms
Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Prostatitis
Evaluation of seminal plasma parameters in patients with chronic prostatitis or leukocytospermia.
Proteinuria
In vitro immunoglobulin production by peripheral blood mononuclear cells as a prognostic factor in IgA nephropathy.
Proteinuria
[Incidence, etiology and prognostic value of persistent significant proteinuria in kidney transplants]
Pseudobulbar Palsy
[Widespread argentophilic structures in progressive supranuclear palsy--an autopsy case report]
Psoriasis
Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.
Psychomotor Agitation
Restless legs syndrome, leg motor restlessness and their variants in patients with Parkinson's disease and related disorders.
Pulmonary Atelectasis
Complete atelectasis of the lung in patients with primary spontaneous pneumothorax.
Pulmonary Atelectasis
Conservative management of a complete primary spontaneous pneumothorax.
Pulmonary Atelectasis
How should complete lung collapse secondary to primary spontaneous pneumothorax be managed??.
Pulmonary Atelectasis
The incidence and risk factors of asymptomatic primary spontaneous pneumothorax detected during health check-ups.
Pulmonary Atelectasis
Uniportal video assisted thoracoscopic surgery bullectomy and double pleurodesis for primary spontaneous pneumothorax.
Pulmonary Disease, Chronic Obstructive
Clinical Profile of Spontaneous Pneumothorax in Adults: A Retrospective Study.
Pulmonary Disease, Chronic Obstructive
Neural control of pressure support ventilation improved patient-ventilator synchrony in patients with different respiratory system mechanical properties: a prospective, crossover trial.
Pulmonary Disease, Chronic Obstructive
Neural versus pneumatic control of pressure support in patients with chronic obstructive pulmonary diseases at different levels of positive end expiratory pressure: a physiological study.
Pulmonary Disease, Chronic Obstructive
Small-bore catheter versus chest tube drainage for pneumothorax.
Rectal Prolapse
Functional outcome after perineal stapled prolapse resection for external rectal prolapse.
Rectal Prolapse
Perineal stapled prolapse resection for full thickness external rectal prolapse: a multicentre prospective study.
Reflex, Abnormal
Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy.
REM Sleep Behavior Disorder
Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: A prospective study.
REM Sleep Behavior Disorder
Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension.
Renal Insufficiency, Chronic
A validation of presepsin levels in kidney dysfunction patients: four case reports.
Respiratory Insufficiency
Alterations of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic produced in rat brain tissues after systemic administration of saxitoxin.
Respiratory Insufficiency
New setting of neurally adjusted ventilatory assist for noninvasive ventilation by facial mask: a physiologic study.
Respiratory Insufficiency
[Clinical analysis of paralytic shellfish poisoning following ingestion of oysters]
Respiratory Paralysis
Shellfish contamination with marine biotoxins in Portugal and spring tides: a dangerous health coincidence.
Respiratory Tract Infections
Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP).
Retinal Degeneration
Drosophila retinal degeneration C (rdgC) encodes a novel serine/threonine protein phosphatase.
Retinal Degeneration
Molecular cloning, expression, and characterization of a novel human serine/threonine protein phosphatase, PP7, that is homologous to Drosophila retinal degeneration C gene product (rdgC).
Retinal Degeneration
Regulatory arrestin cycle secures the fidelity and maintenance of the fly photoreceptor cell.
Rhinitis, Allergic
Polypoid Change of the Middle Turbinate and Paranasal Sinus Polyposis Are Distinct Entities.
Root Resorption
Comparison of cone-beam computed tomography with intraoral photostimulable phosphor imaging plate for diagnosis of endodontic complications: a simulation study.
Root Resorption
Diagnosis of artificially induced external root resorption using conventional intraoral film radiography, CCD, and PSP: an ex vivo study.
Root Resorption
Diagnosis of Simulated External Root Resorption Using Conventional Intraoral Film Radiography, CCD, PSP, and CBCT: A Comparison Study.
Root Resorption
Diagnostic Accuracy of Charge-coupled Device Sensor and Photostimulable Phosphor Plate Receptor in the Detection of External Root Resorption In Vitro.
Sarcoma
In vivo antioxidant, hypoglycemic, and anti-tumor activities of anthocyanin extracts from purple sweet potato.
Scoliosis
A comparison between the Cotrel-Dubousset and the pedicle screw-plate instrumentations in the adolescent idiopathic scoliosis.
Scoliosis
Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Seizures
Lesion of the tuberomammillary nucleus E2-region attenuates postictal seizure protection in rats.
Seizures
Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models.
Sepsis
Concomitant assessment of PSP and NT-proCNP as predictive markers of sepsis in severe trauma patients under mechanical ventilation.
Sepsis
Expression of Pancreatic Stone Protein is Unaffected by Trauma and Subsequent Surgery in Burn Patients.
Sepsis
Incidence and Time Point of Sepsis Detection as Related to Different Sepsis Definitions in Severely Burned Patients and Their Accompanying Time Course of Pro-Inflammatory Biomarkers.
Sepsis
Measurement of pancreatic stone protein in the identification and management of sepsis.
Sepsis
Pancreatic stone protein (PSP) and pancreatitis-associated protein (PAP): a protocol of a cohort study on the diagnostic efficacy and prognostic value of PSP and PAP as postoperative markers of septic complications in patients undergoing abdominal surgery (PSP study).
Sepsis
Pancreatic stone protein and soluble CD25 for infection and sepsis in an emergency department.
Sepsis
Pancreatic Stone Protein Predicts Sepsis in Severely Burned Patients Irrespective of Trauma Severity: A Monocentric Observational Study.
Sepsis
Prognostic performance of pancreatic stone protein in critically ill patients with sepsis.
Sepsis
Prognostic Value of High-Sensitivity C-Reactive Protein, Procalcitonin and Pancreatic Stone Protein in Pediatric Sepsis.
Sepsis
Response of routine inflammatory biomarkers and novel Pancreatic Stone Protein to inhalation injury and its interference with sepsis detection in severely burned patients.
Sepsis
Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care.
Sepsis
Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric study.
Sepsis
The pancreas responds to remote damage and systemic stress by secretion of the pancreatic secretory proteins PSP/regI and PAP/regIII.
Sepsis
[Value of Procalcitonin, High Sensitivity C-reactive Protein and Pancreatic Stone Protein in Predicting Prognosis of Children with Sepsis].
Shock, Septic
Prognostication of Mortality in Critically Ill Patients With Severe Infections.
Sick Sinus Syndrome
[Various diagnostic criteria for abnormal signs of the artificial pacemaker examined by transesophageal electric stimulation of the left atrium]
Sleep Apnea Syndromes
Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy.
Sleep Apnea Syndromes
Predicting poor school performance in children suspected for sleep-disordered breathing.
Sleep Initiation and Maintenance Disorders
Sleep Quality and Mental Disorder Symptoms among Canadian Public Safety Personnel.
Solitary Fibrous Tumors
Huge Pulmonary Sclerosing Pneumocytoma with Endobronchial Invasion: A Case Report with a Literature Review.
Solitary Pulmonary Nodule
Pulmonary sclerosing pneumocytoma mimicking lung cancer: Case report and review of the literature.
Speech Disorders
Motor Speech Disorders and Communication Limitations in Progressive Supranuclear Palsy.
Spinocerebellar Degenerations
An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement.
Spinocerebellar Degenerations
Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia.
Spinocerebellar Degenerations
[An autopsied case of progressive supranuclear palsy, initially diagnosed as spinocerebellar degeneration with severe olivopontocerebellar involvement].
Spondylitis, Ankylosing
Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.
ST Elevation Myocardial Infarction
Presepsin (sCD14-ST): could it be a novel marker for the diagnosis of ST elevation myocardial infarction?
Starvation
Effect of intravenous feeding on wound healing in starvation: an experimental study on the rabbit.
Stomach Neoplasms
A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae).
Stomach Neoplasms
[Resection of gastric carcinoma with preserving of the spleen and pancreas and functional clearance lymph nodes of the spleen hillus and splenic artery]
Striatonigral Degeneration
Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
Striatonigral Degeneration
Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy.
Stroke
A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy.
Stroke
Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and Neuroprotection and Natural History in Parkinson Plus Syndromes Criteria for the Diagnosis of Progressive Supranuclear Palsy.
Stroke
Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
Stroke
Association between nasogastric tubes, pneumonia, and clinical outcomes in acute stroke patients.
Stroke
Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis.
Stroke
Case Report: Barely Able to Speak, Can't Stop Echoing: Echolalic Dynamic Aphasia in Progressive Supranuclear Palsy.
Stroke
Clinical heterogeneity in progressive supranuclear palsy: Problems of clinical diagnostic criteria of NINDS-SPSP in a retrospective study of seven Japanese autopsy cases.
Stroke
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
Stroke
Cough reflex attenuation and swallowing dysfunction in sub-acute post-stroke patients: prevalence, risk factors, and clinical outcome.
Stroke
Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
Stroke
Diagnostic validity of magnetic resonance parkinsonism index in differentiating patients with progressive supranuclear palsy from patients with Parkinson's disease.
Stroke
Post-stroke pneumonia at the stroke unit - a registry based analysis of contributing and protective factors.
Stroke
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders.
Stroke
Progressive supranuclear palsy combined with Alzheimer's disease: A clinicopathological study of two autopsy cases.
Stroke
Progressive supranuclear palsy in a sample of Brazilian population: clinical features of 16 patients.
Stroke
Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome.
Stroke
Risk factors for and impact of poststroke pneumonia in patients with acute ischemic stroke.
Stroke
Risk stratification model for post-stroke pneumonia in patients with acute ischemic stroke.
Stroke
Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy.
Stroke
Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders.
Stroke
Usefulness of the Neutrophil-to-Lymphocyte Ratio as a Predictor of Pneumonia and Urinary Tract Infection Within the First Week After Acute Ischemic Stroke.
Stroke
[Echocardiographic evaluation of mitral stenosis: significance of Pc-To/Ac-Mo ratio (author's transl)]
Subacute Sclerosing Panencephalitis
Descriptive epidemiology of some rare neurological diseases in Benghazi, Libya.
Subclavian Steal Syndrome
Progressive supranuclear palsy in the course of subclavian steal syndrome.
Supranuclear Palsy, Progressive
A new noninvasive test to detect mitochondrial dysfunction of skeletal muscles in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Supranuclear Palsy, Progressive
Accuracy of clinical diagnosis of progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and Neuroprotection and Natural History in Parkinson Plus Syndromes Criteria for the Diagnosis of Progressive Supranuclear Palsy.
Supranuclear Palsy, Progressive
Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
Supranuclear Palsy, Progressive
An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant.
Supranuclear Palsy, Progressive
Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
Supranuclear Palsy, Progressive
APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
Supranuclear Palsy, Progressive
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.
Supranuclear Palsy, Progressive
Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging.
Supranuclear Palsy, Progressive
Association of an extended haplotype in the tau gene with progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Association of Progressive Supranuclear Palsy Rating Scale with Progressive Supranuclear Palsy Quality of Life Scale.
Supranuclear Palsy, Progressive
Association of PSP phenotypes with survival: A brain-bank study.
Supranuclear Palsy, Progressive
Association of Tripartite Motif Containing 11 rs564309 with Tau Pathology in Progressive Supranuclear Palsy.
Supranuclear Palsy, Progressive
Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes.
Supranuclear Palsy, Progressive
Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia.
Supranuclear Palsy, Progressive
Balance and eye movement training to improve gait in people with progressive supranuclear palsy: quasi-randomized clinical trial.
Supranuclear Palsy, Progressive
Behavioral changes as the earliest clinical manifestation of progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Supranuclear Palsy, Progressive
Blood-Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic Encephalopathy.
Supranuclear Palsy, Progressive
Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing.
Supranuclear Palsy, Progressive
Caregiver strain in progressive supranuclear palsy and corticobasal syndromes.
Supranuclear Palsy, Progressive
Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Cerebral oxygen metabolism in patients with progressive supranuclear palsy: a positron emission tomography study.
Supranuclear Palsy, Progressive
Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
Supranuclear Palsy, Progressive
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
Supranuclear Palsy, Progressive
Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study.
Supranuclear Palsy, Progressive
Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
Supranuclear Palsy, Progressive
Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study.
Supranuclear Palsy, Progressive
Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology.
Supranuclear Palsy, Progressive
Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study.
Supranuclear Palsy, Progressive
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
Supranuclear Palsy, Progressive
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy.
Supranuclear Palsy, Progressive
Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy.
Supranuclear Palsy, Progressive
Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
Supranuclear Palsy, Progressive
Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.
Supranuclear Palsy, Progressive
Cognitive impairment in progressive supranuclear palsy-Richardson's syndrome is related to white matter damage.
Supranuclear Palsy, Progressive
Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
Supranuclear Palsy, Progressive
Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy.
Supranuclear Palsy, Progressive
Cortical Alzheimer Type Pathology Does Not Influence tau Pathology in Progressive Supranuclear Palsy.
Supranuclear Palsy, Progressive
Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
Supranuclear Palsy, Progressive
CSF sAPP? and sAPP? levels in Alzheimer's Disease and Multiple Other Neurodegenerative Diseases: A Network Meta-Analysis.
Supranuclear Palsy, Progressive
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.
Supranuclear Palsy, Progressive
Deciphering the saccade velocity profile of progressive supranuclear palsy: A sign of latent cerebellar/brainstem dysfunction?
Supranuclear Palsy, Progressive
DescribePSP and ProPSP: German Multicenter Networks for Standardized Prospective Collection of Clinical Data, Imaging Data, and Biomaterials of Patients With Progressive Supranuclear Palsy.
Supranuclear Palsy, Progressive
Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study.
Supranuclear Palsy, Progressive
Diagnosis and management of progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease.
Supranuclear Palsy, Progressive
Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification.
Supranuclear Palsy, Progressive
Difficulties in the diagnosis of four repeats (4R) tauopathic parkinsonian syndromes.
Supranuclear Palsy, Progressive
Distribution of tuft-shaped astrocytes in the cerebral cortex in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Effect of MAPT and APOE on prognosis of progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Electrophysiological features of lower motor neuron involvement in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
Supranuclear Palsy, Progressive
Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases.
Supranuclear Palsy, Progressive
Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
Supranuclear Palsy, Progressive
Feasibility of short imaging protocols for [18F]PI-2620 tau-PET in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Further extension of the H1 haplotype associated with progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Gait Analysis in Progressive Supranuclear Palsy Phenotypes.
Supranuclear Palsy, Progressive
Gait analysis in PSP and NPH: Dual-task conditions make the difference.
Supranuclear Palsy, Progressive
Health-related quality of life in patients with progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels.
Supranuclear Palsy, Progressive
Impairment of eyeblink classical conditioning in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism.
Supranuclear Palsy, Progressive
In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS.
Supranuclear Palsy, Progressive
Increased Signal in the Superior Cerebellar Peduncle of Patients with Progressive Supranuclear Palsy.
Supranuclear Palsy, Progressive
Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Interhemispheric inhibition in different phenotypes of progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Lack of trigemino-cervical reflexes in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Levodopa-induced facial dystonia in a case of progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study.
Supranuclear Palsy, Progressive
Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity.
Supranuclear Palsy, Progressive
Long-term treatment with rotigotine in drug-naïve PSP patients.
Supranuclear Palsy, Progressive
Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy.
Supranuclear Palsy, Progressive
Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.
Supranuclear Palsy, Progressive
Microtubule-associated protein tau genetic variations are uncommon cause of frontotemporal dementia in south India.
Supranuclear Palsy, Progressive
Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.
Supranuclear Palsy, Progressive
Midbrain catecholaminergic neurons co-express ?-synuclein and tau in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Midbrain MRI assessments in progressive supranuclear palsy subtypes.
Supranuclear Palsy, Progressive
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy.
Supranuclear Palsy, Progressive
Motor, cognitive and behavioral differences in MDS PSP phenotypes.
Supranuclear Palsy, Progressive
MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome.
Supranuclear Palsy, Progressive
Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
Supranuclear Palsy, Progressive
Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau.
Supranuclear Palsy, Progressive
Neuroimaging of PD, PSP, CBD and MSA-PET and SPECT studies.
Supranuclear Palsy, Progressive
Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
New and reliable MRI diagnosis for progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Obsessive compulsive personality disorder in Progressive Supranuclear Palsy, Multiple System Atrophy and Essential Tremor.
Supranuclear Palsy, Progressive
Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses.
Supranuclear Palsy, Progressive
Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Supranuclear Palsy, Progressive
Pedunculopontine Nucleus Deep Brain Stimulation for Parkinsonian Disorders: A Case Series.
Supranuclear Palsy, Progressive
Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Supranuclear Palsy, Progressive
Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study.
Supranuclear Palsy, Progressive
Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis.
Supranuclear Palsy, Progressive
Preliminary studies of differential impairments of the dopaminergic system in subtypes of progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study.
Supranuclear Palsy, Progressive
Progression of gait, speech and swallowing deficits in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability.
Supranuclear Palsy, Progressive
Progression of white matter damage in progressive supranuclear palsy with predominant parkinsonism.
Supranuclear Palsy, Progressive
Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology.
Supranuclear Palsy, Progressive
Progressive Supranuclear Gaze Palsy with Predominant Cerebellar Ataxia: A Case Series with Videos.
Supranuclear Palsy, Progressive
Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.
Supranuclear Palsy, Progressive
Progressive supranuclear palsy with dementia: cortical pathology.
Supranuclear Palsy, Progressive
Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome.
Supranuclear Palsy, Progressive
Progressive supranuclear palsy: a survey of the disease course.
Supranuclear Palsy, Progressive
Progressive supranuclear palsy: neuropathologic and clinical heterogeneity.
Supranuclear Palsy, Progressive
Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism?
Supranuclear Palsy, Progressive
Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
Supranuclear Palsy, Progressive
Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of parkinsonism-dementia complex of Guam but not alzheimer's disease or progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
Supranuclear Palsy, Progressive
Research goals in progressive supranuclear palsy. First International Brainstorming Conference on PSP.
Supranuclear Palsy, Progressive
Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetry.
Supranuclear Palsy, Progressive
Reversible progressive supranuclear palsy-like phenotype as an initial manifestation of HIV infection.
Supranuclear Palsy, Progressive
Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
Supranuclear Palsy, Progressive
Selective decrease of large neurons in the neostriatum in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
Supranuclear Palsy, Progressive
Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms.
Supranuclear Palsy, Progressive
Sleep disturbances in the speech-language variant of progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Supranuclear Palsy, Progressive
Spinal cord stimulation therapy for gait dysfunction in progressive supranuclear palsy patients.
Supranuclear Palsy, Progressive
Structural and functional meta-analytic evidence for fronto-subcortical system deficit in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.
Supranuclear Palsy, Progressive
Substantia nigra echogenicity in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
The auditory startle response in parkinsonism may reveal the extent but not type of pathology.
Supranuclear Palsy, Progressive
The Cure PSP Care Guide: A Telephonic Nursing Intervention for Individuals and Families Living With Progressive Supranuclear Palsy.
Supranuclear Palsy, Progressive
The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy.
Supranuclear Palsy, Progressive
The diagnosis of neurodegenerative disorders based on clinical and pathological findings using an MRI approach.
Supranuclear Palsy, Progressive
The H1c haplotype at the MAPT locus is associated with Alzheimer's disease.
Supranuclear Palsy, Progressive
The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.
Supranuclear Palsy, Progressive
The ratio of square wave jerk rates to blink rates distinguishes progressive supranuclear palsy from Parkinson disease.
Supranuclear Palsy, Progressive
The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome-A Pilot Study.
Supranuclear Palsy, Progressive
Transcranial brain sonography findings in two main variants of progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Treatment of progressive supranuclear palsy with tricyclic antidepressants.
Supranuclear Palsy, Progressive
Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Variation at the TRIM11 Locus Modifies Progressive Supranuclear Palsy Phenotype.
Supranuclear Palsy, Progressive
Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy.
Supranuclear Palsy, Progressive
What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features?
Supranuclear Palsy, Progressive
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
Supranuclear Palsy, Progressive
Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Supranuclear Palsy, Progressive
[A 65-year-old man with Parkinsonism, gaze palsy, and dementia]
Supranuclear Palsy, Progressive
[Adult-onset dementia with abundant neurofibrillary tangles resembling progressive supranuclear palsy]
Supranuclear Palsy, Progressive
[Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report].
Supranuclear Palsy, Progressive
[Progressive supranuclear paralysis. Quantification of dopamine D2 receptors using radionuclide tomography]
Sweating, Gustatory
A meta-analysis of the pros and cons of partial superficial parotidectomy versus superficial parotidectomy for the treatment of benign parotid neoplasms.
Sweating, Gustatory
Superficial or partial superficial parotidectomy for the treatment of primary benign parotid tumors.
Sweating, Gustatory
Superficial parotidectomy versus partial superficial parotidectomy in treating benign parotid tumors.
Sweating, Gustatory
Superficial parotidectomy versus retrograde partial superficial parotidectomy in treating benign salivary gland tumor (pleomorphic adenoma).
Sweating, Gustatory
[Partial superficial parotidectomy versus superficial parotidectomy for treatment of parotid benign tumors: evidence-based medicine analysis].
Sweating, Gustatory
[Sixty-two cases report of surgical treatment of parotid pleomorphic adenoma]
Synucleinopathies
Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism.
Synucleinopathies
Pathologic changes of progressive supranuclear palsy, corticobasal degeneration, and multiple system atrophy : Prototype and clinicopathological diversity.
Synucleinopathies
Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of parkinsonism-dementia complex of Guam but not alzheimer's disease or progressive supranuclear palsy.
Synucleinopathies
Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis.
Synucleinopathies
Serum adiponectin levels between patients with Parkinson's disease and those with PSP.
Tachycardia
Failing Left Ventricles Have an Enhanced Post-Stimulation Potentiation Despite Their Impaired Force Frequency Relationship.
Tachycardia
Mechanical function and substrate oxidation in the neonatal pig heart subjected to pacing-induced tachycardia.
Tachycardia, Sinus
Left stellate ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory dogs with pacing-induced congestive heart failure.
Tachycardia, Ventricular
Prolonged Sinus Pauses upon Termination of Paroxysmal Atrial Fibrillation: Abnormal Right Atrial Electrophysiologic and Electroanatomic Findings.
Tauopathies
4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
Tauopathies
A Novel MAPT Mutation, G55R, in a Frontotemporal Dementia Patient Leads to Altered Tau Function.
Tauopathies
ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans.
Tauopathies
Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia.
Tauopathies
Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies.
Tauopathies
Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration.
Tauopathies
Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
Tauopathies
Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
Tauopathies
Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
Tauopathies
Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
Tauopathies
Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies.
Tauopathies
Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.
Tauopathies
Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases.
Tauopathies
Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases.
Tauopathies
Failure in heat-shock protein expression in response to UBB+1 protein in progressive supranuclear palsy in humans.
Tauopathies
Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273R.
Tauopathies
Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies.
Tauopathies
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study.
Tauopathies
Genetic pleiotropy and the shared pathological features of corticobasal degeneration and progressive supranuclear palsy: a case report and a review of the literature.
Tauopathies
Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies.
Tauopathies
Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Tauopathies
Heavy metals contaminating the environment of a progressive supranuclear palsy cluster induce tau accumulation and cell death in cultured neurons.
Tauopathies
Human tau pathology transmits glial tau aggregates in the absence of neuronal tau.
Tauopathies
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
Tauopathies
Mechanisms of Neurodegeneration in Various Forms of Parkinsonism-Similarities and Differences.
Tauopathies
Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP).
Tauopathies
Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy.
Tauopathies
Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome.
Tauopathies
Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers.
Tauopathies
Parkinsonian Syndrome with Frontal Lobe Involvement and Anti-Glycine Receptor Antibodies.
Tauopathies
Pathologic changes of progressive supranuclear palsy, corticobasal degeneration, and multiple system atrophy : Prototype and clinicopathological diversity.
Tauopathies
Pathological and Clinical Spectrum of Progressive Supranuclear Palsy: With Special Reference to Astrocytic Tau Pathology.
Tauopathies
Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.
Tauopathies
PBB3 imaging in Parkinsonian disorders: Evidence for binding to tau and other proteins.
Tauopathies
PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.
Tauopathies
Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy.
Tauopathies
Post mortem cerebrospinal fluid ?-synuclein levels are raised in multiple system atrophy and distinguish this from the other ?-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
Tauopathies
Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD.
Tauopathies
Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options.
Tauopathies
Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.
Tauopathies
Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.
Tauopathies
Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of parkinsonism-dementia complex of Guam but not alzheimer's disease or progressive supranuclear palsy.
Tauopathies
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
Tauopathies
Selective Vulnerability of Brainstem Nuclei in Distinct Tauopathies: A Postmortem Study.
Tauopathies
Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.
Tauopathies
Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.
Tauopathies
Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration.
Tauopathies
Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy.
Tauopathies
Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Tauopathies
Tauopathy with Hippocampal 4-Repeat Tau Immunoreactive Spherical Inclusions in a Patient with PSP.
Tauopathies
The diagnosis of progressive supranuclear palsy: current opinions and challenges.
Tauopathies
The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis.
Tauopathies
The MAPT gene is differentially methylated in the progressive supranuclear palsy brain.
Tauopathies
Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans.
Tauopathies
Unexpected abundance of pathological tau in progressive supranuclear palsy white matter.
Tauopathies
Variation in tau isoform expression in different brain regions and disease states.
Tauopathies
[Amyotrophic lateral sclerosis-parkinsonism-dementia complex of the Kii Peninsula of Japan]
Tauopathies
[Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report].
Tetanus
Blockade of NMDA receptors unmasks a long-term depression in synaptic efficacy in rat prefrontal neurons in vitro.
Tetanus
Short-term synaptic plasticity contributes to the temporal filtering of electrosensory information.
Tetralogy of Fallot
Three-step preoperative sequential planning for pulmonary valve replacement in repaired tetralogy of Fallot using computed tomography.
Thiamine Deficiency
Progressive supranuclear palsy responding to intravenous thiamine: superimposed Wernicke's encephalopathy?
Thrombosis
Impact of PSP Technique on Clinical Outcomes Following Bioresorbable Scaffolds Implantation.
Thrombosis
Poor Subpleural Perfusion Predicts Failure After Balloon Pulmonary Angioplasty for Nonoperable Chronic Thromboembolic Pulmonary Hypertension.
Thrombosis
The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP).
Thrombosis
Undiscovered pathology of transient scaffolding t1remains a driver of failures in clinical trials.
Tic Disorders
Premonitory urges are associated with decreased grey matter thickness within the insula and sensorimotor cortex in young people with Tourette syndrome.
Tics
Premonitory sensory phenomena and suppressibility of tics in Tourette syndrome: developmental aspects in children and adolescents.
Tics
Premonitory urges are associated with decreased grey matter thickness within the insula and sensorimotor cortex in young people with Tourette syndrome.
Tourette Syndrome
Premonitory sensory phenomena and suppressibility of tics in Tourette syndrome: developmental aspects in children and adolescents.
Tremor
Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale.
Tremor
Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Tremor
Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia.
Tremor
Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy.
Tremor
Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank.
Tremor
Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Tremor
The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.
Tremor
Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects.
Tuberculosis
Bilateral primary spontaneous pneumothorax with multiple bleb performed by VATS and wedge resection: A rare case in Indonesian adult and review article.
Tuberculosis
Biochemical characterization of phosphoserine phosphatase SerB2 from Mycobacterium marinum.
Tuberculosis
Characterization of M. tuberculosis SerB2, an essential HAD-family phosphatase, reveals novel properties.
Tuberculosis
Global discovery the PstP interactions using Mtb proteome microarray and revealing novel connections with EthR.
Tuberculosis
High Throughput Screen Identifies Small Molecule Inhibitors Specific for Mycobacterium tuberculosis Phosphoserine Phosphatase.
Tuberculosis
Identification and Repurposing of Trisubstituted Harmine Derivatives as Novel Inhibitors of Mycobacterium tuberculosis Phosphoserine Phosphatase.
Tuberculosis
Regulatory Mechanism of Mycobacterium tuberculosis Phosphoserine Phosphatase SerB2.
Tuberculosis
Rv2744c is a PspA ortholog that regulates lipid droplet homeostasis and non-replicating persistence in Mycobacterium tuberculosis.
Tuberculosis
Serine/Threonine Protein Phosphatase PstP of Mycobacterium tuberculosis Is Necessary for Accurate Cell Division and Survival of Pathogen.
Tuberculosis
The Psp system of Mycobacterium tuberculosis integrates envelope stress-sensing and envelope-preserving functions.
Tuberculosis, Pulmonary
Aetiology and clinical profile of spontaneous pneumothorax in adults.
Urinary Incontinence
Nocturnal manifestations of atypical and vascular parkinsonism: How do they differ from Parkinson's disease?
Uterine Cervical Neoplasms
A novel design for estimating relative accuracy of screening tests when complete disease verification is not feasible.
Uterine Cervical Neoplasms
[Evaluation of PSP excretion test in diagnosis of the upper urinary tract disturbances in cases of postoperative cervical cancer]
Uveitis
Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.
Vascular Diseases
A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy.
Virus Diseases
Pinon shell polysaccharide enhances immunity against H9N2 avian influenza virus in chickens.
Virus Diseases
Serine/threonine protein phosphatase is required for tobacco mosaic virus-mediated programmed cell death.
Wernicke Encephalopathy
Progressive supranuclear palsy responding to intravenous thiamine: superimposed Wernicke's encephalopathy?
Xerostomia
A meta-analysis of the pros and cons of partial superficial parotidectomy versus superficial parotidectomy for the treatment of benign parotid neoplasms.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ORGANISM
COMMENTARY
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
SOURCE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY
GeneOntology No.
LITERATURE
SOURCE
-
cytoplasmic protein in keratinocytes that primarily localizes to endosomes
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
malfunction
-
knock down of PSPH dramatically diminishes squamous cell carcinoma cell proliferation and cyclin D1 levels in the presence of exogenous of L-serine production suggesting a non-canonical role for PSPH in epithelial carcinogenesis
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable).
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). SERB_HUMAN
225
0
25008
Swiss-Prot
other Location (Reliability: 2)
Q53EY1_HUMAN
225
0
24949
TrEMBL
other Location (Reliability: 2)
A0A024RDL3_HUMAN
225
0
25008
TrEMBL
other Location (Reliability: 2)
A0A024RDL9_HUMAN
252
0
28082
TrEMBL
Mitochondrion (Reliability: 2)
C9JBI3_HUMAN
187
0
20745
TrEMBL
other Location (Reliability: 2)
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PDB
SCOP
CATH
UNIPROT
ORGANISM
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
hanging drop vapour-diffusion method. A resolution of 1.53 A provides a detailed model of the active site in a completely open conformation and the water molecules bound to it
-
replacement of sixfold coordinated Mg2+ in active site by Ca2+ results in sevenfold coordinated metal ion, explaining the inhibitory effect of Ca2+
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
E29D
-
less than 5% of the activity of wild-type enzyme with L-phosphoserine as substrate
N133A
-
about 25% of the activity of wild-type enzyme with L-phosphoserine as substrate
N133D
-
about 130% of the activity of wild-type enzyme with L-phosphoserine as substrate
R202K
-
less than 5% of the activity of wild-type enzyme with L-phosphoserine as substrate
S23A
-
about 50% of the activity of wild-type enzyme with L-phosphoserine as substrate
S23T
-
about 20% of the activity of wild-type enzyme with L-phosphoserine as substrate
T182S
-
about 5% of the activity of wild-type enzyme with L-phosphoserine as substrate
T182V
-
about 75% of the activity of wild-type enzyme with L-phosphoserine as substrate
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
EXPRESSION
ORGANISM
UNIPROT
LITERATURE
the enzyme activity is elevated in patients with schizophrenia, especially in male patients
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
APPLICATION
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
medicine
medicine
enzyme inhibition enhances the anticancer efficacy of 5-fluorouracil in colorectal cancer
medicine
the enzyme is a prognostic biomarker in colorectal cancer and positively correlated with depth of invasion and distant metastasis
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Shetty, V.; Shetty, K.T.
Phosphoserine phosphatase of human brain: partial purification, characterization, regional distribution, and effect of certain modulators including psychoactive drugs
Neurochem. Res.
16
1203-1210
1991
Homo sapiens
-
brenda
Peeraer, Y.; Rabijns, A.; Verboven, C.; Collet, J.F.; Van Schaftingen, E.; De Ranter, C.
Purification, crystallization and preliminary X-ray diffraction analysis of human phosphoserine phosphatase
Acta Crystallogr. Sect. D
58
133-134
2002
Homo sapiens
brenda
Peeraer, Y.; Rabijns, A.; Verboven, C.; Collet, J.F.; Van Schaftingen, E.; De Ranter, C.
High-resolution structure of human phosphoserine phosphatase in open conformation
Acta Crystallogr. Sect. D
59
971-977
2003
Homo sapiens
brenda
Kim, H.Y.; Heo, Y.S.; Kim, J.H.; Park, M.H.; Moon, J.; Kim, E.; Kwon, D.; Yoon, J.; Shin, D.; Jeong, E.J.; Park, S.Y.; Lee, T.G.; Jeon, Y.H.; Ro, S.; Cho, J.M.; Hwang, K.Y.
Molecular basis for the local conformational rearrangement of human phosphoserine phosphatase
J. Biol. Chem.
277
46651-46658
2002
Homo sapiens
brenda
Peeraer, Y.; Rabijns, A.; Collet, J.F.; Van Schaftingen, E.; De Ranter, C.
How calcium inhibits the magnesium-dependent enzyme human phosphoserine phosphatase
Eur. J. Biochem.
271
3421-3427
2004
Homo sapiens
brenda
Pollari, S.; Kaekoenen, S.M.; Edgren, H.; Wolf, M.; Kohonen, P.; Sara, H.; Guise, T.; Nees, M.; Kallioniemi, O.
Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis
Breast Cancer Res. Treat.
125
421-430
2011
Homo sapiens
brenda
Bachelor, M.A.; Lu, Y.; Owens, D.M.
L-3-Phosphoserine phosphatase (PSPH) regulates cutaneous squamous cell carcinoma proliferation independent of L-serine biosynthesis
J. Dermatol. Sci.
63
164-172
2011
Homo sapiens
brenda
Sato, K.; Masuda, T.; Hu, Q.; Tobo, T.; Kidogami, S.; Ogawa, Y.; Saito, T.; Nambara, S.; Komatsu, H.; Hirata, H.; Sakimura, S.; Uchi, R.; Hayashi, N.; Iguchi, T.; Eguchi, H.; Ito, S.; Nakagawa, T.; Mimori, K.
Phosphoserine phosphatase is a novel prognostic biomarker on chromosome 7 in colorectal cancer
Anticancer Res.
37
2365-2371
2017
Homo sapiens (P78330)
brenda
Li, X.; Xun, Z.; Yang, Y.
Inhibition of phosphoserine phosphatase enhances the anticancer efficacy of 5-fluorouracil in colorectal cancer
Biochem. Biophys. Res. Commun.
477
633-639
2016
Homo sapiens (P78330), Homo sapiens
brenda
Ozeki, Y.; Sekine, M.; Fujii, K.; Watanabe, T.; Okayasu, H.; Takano, Y.; Shinozaki, T.; Aoki, A.; Akiyama, K.; Homma, H.; Shimoda, K.
Phosphoserine phosphatase activity is elevated and correlates negatively with plasma D-serine concentration in patients with schizophrenia
Psychiatry Res.
237
344-350
2016
Homo sapiens (P78330), Homo sapiens
brenda
EXTERNAL LINKS (specific for EC-Number 3.1.3.3)
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
About BRENDA
Social media
Help
Survey
Download
Contribution
Legal
Curated at
Member of
